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Crohn’s disease (CD) is a chronic inflammatory disease predominantly affecting the terminal 
ileum. The ~200 CD-risk loci identified by genome-wide association studies (GWAS) are 
enriched for genes involved in T-cell signalling, highlighting the importance of T cells in CD 
pathology
1,2
. It is crucial to study T cells in their disease-relevant context: the intestinal mucosa. 
Although human single-cell atlases are in development
3
, location- and disease-specific single-
cell RNA sequencing (scRNAseq) datasets are still scarce. Here we use scRNAseq of disease-
relevant cells to examine pathomechanisms and identify potential drug targets on a cellular 
level in CD.  
 
Methods:  
We performed flow-cytometry and scRNAseq of 5,292 CD3-positive T cells isolated from 
peripheral blood (PBL) and ileal biopsies of three CD patients with mild to moderate disease 
activity (Figure 1, step 1). Biopsies were dissociated and separated into intraepithelial T 
lymphocytes (IEL) and lamina propria T lymphocytes (LPL)
4
. We then integrated T-cell 
transcriptomes with GWAS CD-risk loci and drug-target identification resources. Through 
literature search and online database analysis, we identified 179 CD-risk genes and 2,712 drug-
target genes that we aligned to differentially expressed genes. Finally, we selected genes 




After quality control, 4,070 T cells remained for analysis. These cells expressed 966 genes per 
cell, on average, and 41,134 distinct genes in total (Figure 1, step 2).  IEL, LPL and PBL showed 
markedly different expression profiles (Supplementary Figure 1, Supplementary Table 1).  
Unsupervised clustering of scRNAseq data identified 6 distinct T-cell types that have different 
distributions in IEL, LPL and PBL: cytotoxic T lymphocytes (CTL) dominate the IEL, quiescent T 
cells dominate the PBL reservoir, and T-helper 17 (Th17) cells dominate the LPL (Figure 1, step 













quiescent T cells (Treg/Quiescent cells). Treg/Quiescent cells were also present in the IEL and 
LPL. In both the IEL and LPL, we identified a cluster of cells of a previously undefined cell type 
characterized by expression of both CD3 and REG1A/B, and confirmed this with 
immunofluorescence staining. All T-cell subtypes were present in all patients.  
 
Strikingly, all cell-subtype clusters consisted of both epitopic CD8αβ-positive and –negative 
cells. Moreover, CD8A and CD8B transcripts were expressed in both epitopic CD8αβ-positive 





Using permutation analysis, we found that both IEL and LPL expressed significantly more CD-risk 
genes than expected by chance (P=0.00389 and P<0.00001, respectively), suggesting that cells 
within these compartments play a role in CD inflammation
2
. PBL were not enriched for CD-risk-
gene expression (P=0.45954). Th17 cells show the highest number of overexpressed CD-risk 
genes and are most specifically enriched for CD-risk-gene expression (P<0.00001). Mucosal CTL 
and Treg/Quiescent and peripheral blood Effector/Treg cells are also significantly enriched for 
CD-risk-gene expression (P=0.0278, P=0.02477 and P=0.00081, respectively).   
 
We investigated which drug targets are expressed by Th17 and CTL, both cell types with well-
characterized expression signatures that play a central role in CD pathogenesis (Table 1). Th17 
cells showed upregulation of IL17A, whose gene product is targeted by Secukinumab. ITGAE, 
whose gene product is targeted by Etrolizumab, is upregulated in mucosal CTL. S1PR5, 
upregulated in peripheral blood CTL, is a known drug target for Ozanimod. Potential targets for 
drug repositioning include: PDE4D in mucosal Th17 cells, a target for Apremilast, under 
investigation for treatment of ulcerative colitis; ITGB2 in peripheral blood CTL, a target for 
Lifitegrast, approved for keratoconjunctivitis sicca; and ALOX5AP in mucosal CTL, a target for 















We have demonstrated that multiple ileal mucosal T-cell subtypes and one peripheral blood T-
cell subtype from CD patients are enriched for CD-risk-gene expression. T-cell subtypes known 
to be involved in CD pathogenesis provide promising targets for future cell-type-specific 
therapies in CD patients. A limitation of our study is the small sample size, which may reduce 
the amount of variation covered. However, most cell-type-specific gene-expression signatures 
remained after correcting for inter-individual differences. As location- and disease-specific 
scRNAseq data are still limited, detailed datasets like ours are an important reference for 
furthering our understanding of the molecular processes leading to health and disease and 
















1. Liu JZ, van Sommeren S, et al. Nat Genet 2015;47:979–986. 
2. Farh KK-H, Marson A, et al. Nature 2015;518:337–43. 
3. Regev A, et al. Elife 2017;6;e27041 
4. Raine T, et al. Gut 2015;64:250–259. 
5. Zheng GXY, et al. Nat Commun 2017;8:14049. 
 




















Figure 1: Experimental flow chart. EDTA and collagenase are treatments used to isolate 
intraepithelial and lamina propria cells, respectively. T-cell-subtype characterization as 
described in Supplementary Methods. In brackets: number of epitopic CD8αβ-positive T cells 
measured by flow-cytometry. IEL: intraepithelial T lymphocyte. LPL: lamina propria T 
















Table 1: Overexpression of CD-risk genes and genes encoding potential drug targets in ileal mucosal Th17 cells and cytotoxic T lymphocytes 
  mucosal Th17 cells peripheral blood CTL mucosal CTL 
  Gene Function Gene Function Gene Function 
CD-risk gene CCL20 Chemoattractant for various 
immune cells 
CTSW Regulation of T cell cytolytic 
activity 
PLCG2 Transmembrane signaling of 
immune system receptors 
  DNAJB4 Heat shock protein, 
involved in protein folding 
LSP1 Adhesion and trans endothelial 
migration 
PTPN22 Negative regulator of TCR signaling, 
positive regulator of TLR signaling 
  IFNG Cytokine, involved in 
adaptive/innate immunity 
PRKCB Apoptosis regulation SOCS1 Cytokine-inducible negative 
regulation of cytokine signaling 
  IRF4 Regulation of mucosal Th17 
cell differentiation 
PTPRC T cell antigen receptor signaling 
regulation 
  
  MAP3K8 T-helper cell differentiation 
and IFNγ expression 
     
 Gene Drug or compound Gene Drug or compound Gene Drug or compound 
Known CD-drug 
target 
IL17A Secukinumab S1PR5 Ozanimod CD3D/E/G NI-0401 
      FCGR3A IgG class mAbs* ITGAE Etrolizumab 
          CCR9 Vercirnon 
          TGFBR1 Mongersen*** 
Candidate for drug 
repositioning 
DNAJB1 Apatorsen CCL5 Heparin compounds CCL5 Heparin compounds 
  SIK1 Dabrafanib
 
FGR Dasatinib ADRB1 STD-101-D1 
  HSP90AA1 Nedocromil FCGR3A IgG class mAbs** ALOX5AP Fiboflapon 
  PTGER4 Rivenprost; Limaprost; 
Dinoproston 
ITGB2 Lifitegrast SLAMF7 Elotuzumab 
  PDE4D Apremilast ADRB2 Beta-2 adrenergic receptor 
blockers 














Legend: Ileal mucosal Th17 cells, peripheral blood cytotoxic T lymphocytes (CTL) and ileal mucosal CTL show the highest number of 
significantly overexpressed CD-risk genes. The top 5 most significantly overexpressed CD-risk genes are shown in the first row of this table; 
Per cell type, the top 5 most significantly overexpressed known CD-drug targets and candidates for drug repositioning are shown. Selection 
of CD-risk genes is explained in ‘Supplementary Methods: CD-risk genes’. ‘Known CD-drug target’ refers to genes encoding targets for drugs 
currently approved or under investigation for treatment of CD in humans. ‘Candidate for drug repositioning’ refers to genes encoding targets 
for drugs currently approved or under investigation in humans for other diseases than CD. (see 'Supplementary Methods: Drug-target genes’) 
CD: Crohn's disease; Th17: T-helper 17 cells; CTL: cytotoxic T lymphocyte 
*[e.g. Adalimumab; Etanercept; Natalizumab] 
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For details of antibodies, reagents, kits and software used see Supplementary Table 2.  
 
Patient selection and sample collection 
For this study, we recruited one male and two female patients (ages 36, 25, and 48, 
respectively) with mild to moderate Crohn’s disease (CD). Written informed consent was 
obtained and ethical approval was granted by the University Medical Center Groningen 
Ethics Committee. All three patients had been diagnosed with histologically proven ileal CD 
at least five years earlier. None had undergone surgical resections. For each patient, five 
pinch biopsies were collected from mildly inflamed terminal ileum: the most common site of 
inflammation in CD and a clear anatomical landmark.  
Biopsies were collected into RPMI 1640 medium on ice and processed immediately. 10 mL of 
peripheral blood was collected subsequently in tubes containing 158 USP units lithium-
heparin.  
Tissue processing 
Ileal biopsies were dissociated into single cells following a previously published protocol
1
, 
separating IEL and LPL fractions using EDTA+DTT and collagenase digestion. RNAse-mediated 
RNA degradation was limited by adding 15µl RNAse Superase™ before collagenase digestion. 
PBL were isolated using density gradient centrifugation with Lymphoprep™ solution. Tissue 
processing, except for collagenase incubation, was performed on ice.  
Flow Cytometry of single-cell suspensions  
All cell suspensions (IEL, LPL and PBL) were stained with the same antibody panel comprising 
propidium iodide and monoclonal antibodies to TCRαβ, CD3, CD8α, CD8β, CD19, CD45RO, 
CD62L and CD326.  
Cells were sorted using the MoFlo Astrios (Beckman Coulter, Inc.), using forward- and side-
scatter signals to define lymphocyte fraction and exclude unwanted events such as debris, 
non-viable cells and doublets. CD3+TCRαβ+ lymphocytes were sorted one-cell-per-well into 
384-well plates containing cell lysis buffer, on ice (see ‘Single-cell RNA library preparation 













low pressures. After sorting, each cell was collected in a well containing lysis buffer 
consisting of dNTP mix, Oligo dT primer, Triton X-100 and RNase inhibitor. 
Single-cell RNA library preparation and sequencing  
Single-cell transcriptome libraries were created using a protocol based on Smart-Seq2 library 
preparation using 3’-paired-end sequencing
2
. After a 3-minute incubation/ligation step at 
72°C, a TSO-primer containing Unique Molecular Identifiers (UMIs) was bound to the poly-A 
tail of RNA transcripts, after which these were reverse transcribed using SmartScribe reverse 
transcriptase. Next, the barcoded complementary DNA (cDNA) were amplified using BC-PCR 
primers. To eliminate short fragments, cDNA products were purified with 0.8X ratio 
Agencourt Ampure XP beads. Following purification, tagmented libraries were constructed 
with the Nextera XT DNA preparation kit. To allow multiplexed high-throughput sequencing, 
cells were pooled with N7xx Nextera primer barcoding, enabling in silico sorting. Following 
amplification, products were cleaned with 0.6X ratio Agencourt Ampure XP beads. To check 
for size distribution of the cDNA product, the product was measured repeatedly on a 
PerkinElmer LabChip GX high-sensitivity DNA chip. After final quality check of amplified and 
purified products, pools were combined into superpools (8 barcoded pools/superpool–672 
cells/superpool) and sequenced on the Illumina NextSeq500 sequencer with 400M 75bp 
paired-end reads.  
scRNAseq de-multiplexing pipeline 
We obtained sequencing data for 5,292 single cells, with an average of ~400,000 reads per 
cell (Figure 1, step 2). Sequencing data was processed through a de-multiplexing pipeline. 
Reads with a Hamming distance >1 and an average quality score ≤10 were excluded. 
Trimmed fastQ files were aligned to the human reference genome (Ensemble release 75, 
GRCh37) using STAR (v. 2.5.1b)
3
 with default settings. Approximately 75% of reads mapped 
uniquely. Before gene quantification, Picardtools (v. 2.2.2)
4
 was used to sort aligned reads 
and flag individual cells and UMIs. Gene level quantification was performed using Dropseq 
and filtering read count on unique UMIs, resulting in a gene/cell UMI count matrix.  













UMI counts were processed using Seurat
5
. To correct for cell-to-cell gene detection 
differences, we log-normalized UMI counts per cell and excluded genes expressed in <3 cells. 
To control for low quality cells and doublets, we excluded cells expressing <200 genes per 
cell, cells expressing >2500 genes per cell and cells with >5% mitochondrial genes. (Figure 1, 
step 2). We performed a principal component (PC) analysis and found that patient/batch, 
tissue-of-origin, and number of UMIs were the major drivers among the first 6 PCs. For our 
analyses, we regressed out the number of UMIs and percentage mitochondrial expression. 
Interpatient differences were assessed in differential expression analyses. Since differential 
expression between different tissues-of-origin may be partially driven by altered gene 
expression induced by collagenase digestion, we excluded 127 genes previously found to be 
influenced by collagenase digestion
6
. 
Integrating flow-cytometry and RNA expression data 
Flow-cytometry data was analyzed using Kaluza software (Beckman Coulter Inc.). Positivity 
for any epitope was determined by visual inspection of plots with staining intensities. This 
adjudication process was cross-checked by a flow-cytometry expert. We used Summit 
software (Beckman Coulter Inc.) to extract intensity data per cell into a CSV file format. Data 
on positivity for epitope per cell was merged with metadata of the Seurat data file.  
Clustering 
Cells were clustered using a K-nearest-neighbor-based method
5 
(Figure 1, step 3). Clustering 
was done with the PCs that were significant in a null-distribution determined through 
JackStraw analysis. We varied clustering resolution between 0.6 and 1.2, and settled on 0.6 
because higher resolution produced clusters defined by marginal differential gene 
expression. Different subsets (based on tissue-of-origin and the CD8αβ epitope) were 
clustered separately to check for subset-specific cell types and/or states. tSNE reduction was 
used for visualization purposes.  
Identification of T-cell subtypes in intestinal mucosa   
In order to stratify cell types, we first defined cells with a quiescent profile based on 
expression of CCR7 and cells with an effector profile based on expression of CD160. The 













on a quiescent background (Treg/Quiescent), Cytotoxic T cells (CTL), and a group of 
REG1A/1B-expressing cells. (Figure 1, Supplementary Figure 1, Supplementary Table 1). 
CTL were identified based on expression of EOMES, PRF1 and TBX21; cytotoxic enzymes such 
as GNLY, GZMH and GZMB; and genes for cytokines with a strong chemoattractant function 
such as CCL4 and CCL5 or XCL1, XCL2 and ITGA1. Treg/Quiescent cells were characterized by 
expression of TNFRSF4, FOXP3, CCR7, IL6ST, NOG and SELL. Th17 cells were characterized by 
expression of IL17A, IL22 and IRF4 and transcription factors typical for Th17 cell function 
such as NR4A2 and CREM. 
Finally, we identified a much smaller group of cells that could not be defined based on 
published genetic markers. These cells express high levels of REG1A/1B and show co-
expression of CD3E/G and EPCAM. Immunofluorescence staining of ileal mucosa of CD 
patients confirmed the presence of these cells in the mucosa, expressing both CD3 and 
REG1A proteins. 
Identification of T-cell subtypes in peripheral blood   
Within the PBL population, we found CTL, Quiescent cells, Effector/Treg cells and 
Treg/Quiescent cells (Figure 1, Supplementary Table 1). Quiescent T cells were 
characterized based on expression of CCR7, IL6ST, SELL, NOG and TCF7 (Supplementary 
Table 1). A second cluster of cells with a quiescent profile express TNFRSF4, and these were 
characterized as Treg/Quiescent cells through expression of TNFRSF4 and LTB, MTA2 and 
HNRPH1. Effector/Treg were characterized by expression of TNFRSF4 and ITGAE, IL32, 
FOXP3, PRDM1 and CMTM6. Finally, CTL were characterized based on high expression of 
marker genes such as EOMES, PRF1 and TBX21 and the above-mentioned genes GNLY, 
GZMH, GZMB, CCL4 and CCL5 (Supplementary Table 1). 
Differential expression analysis 
Differential expression analysis was done using the MAST function in Seurat (Figure 1, step 
3). Differential expression was calculated between tissues-of-origin and cell types. To classify 
only genes that are expressed at least moderately, we filtered out genes expressed in less 
than 1% of the cells. After Bonferroni correction for multiple testing, results were considered 
significant at an adjusted P-value <0.05. Regressing out the effects of individual patient and 













subtype-specific gene-expression signatures overlapped between analyses (data not shown). 
To capture subtle changes in expression, we used the non-regressed data for subsequent 
analyses.  
CD-risk genes  
Through literature search, we identified 179 CD-risk genes. From each genome-wide 
association study (GWAS) risk locus, we selected the gene implicated through coding 
variants or functional variants. If multiple genes were implicated within a locus, the genes 
implicated through functional evidence were selected. Three loci remained in which two 
genes were implicated, and all were included in further analysis. If no functional or coding 
data was available, the most likely implicated gene (generally implicated indirectly through 
functional studies) was selected. Since scRNAseq detects overexpression more robustly than 
underexpression, and a previous study showed that CD-risk genes dysregulated between CD 




Drug-target genes  
We aligned IBD drug-target genes extracted from OpenTargets
8
 (n=2,712) and Drugbank
9
, to 
differentially expressed genes, and subsequently selected genes encoding proteins targeted 
by drugs currently available for (clinical trials in) humans.  
Comparison with scRNAseq dataset of T cells from healthy subjects  
We studied publicly available scRNAseq data of epitopic CD4-positive naïve T cells for their 
mRNA expression of genes typically associated with epitopic CD8αβ-positive T cells10.  
Enrichment for CD-risk gene expression 
We assessed whether T-cell subtypes showed enrichment for expression of CD-risk genes. 
We created null-distributions by randomly selecting sets the size of the differentially 
expressed genes per cell type from the total set of 12,531 genes. Empirical P-values of 
overrepresentation of CD-risk genes within cell-type-specific differentially expressed gene 
sets were derived from the null-distributions generated from 10
5
 rounds of random 
sampling.  













The scripts used can be found at https://github.com/WeersmaLabIBD/SingleCell. Summit 
can be obtained from Beckman Coulter. The raw data is available at https://ega-archive.org 
(EGAS00001002702).  
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Supplementary Table 1: T-cell expression signatures specific to T-cell subsets 
 
Legend: T-cell subsets were characterized based on marker genes (see Supplementary 
Methods). Genes shown are significantly overexpressed in the specified cell type relative to 
all other cell types. The 'Gene annotation' column indicates whether a gene is a CD-risk 
gene, a drug-target gene (as described Supplementary Methods sections: ‘CD-risk genes’ and 
‘Drug-target genes’), a transcription factor or encodes a cytokine.  







Compartment Cell type Gene 
annotation 
GNLY 3.11E+00 3.60E-201 Peripheral blood CTL  
GZMH 2.43E+00 3.23E-166 Peripheral blood CTL  
NKG7 1.89E+00 2.24E-136 Peripheral blood CTL  
PRF1 1.88E+00 2.44E-123 Peripheral blood CTL  
GZMB 2.26E+00 2.41E-106 Peripheral blood CTL  
ADGRG1 1.89E+00 1.56E-101 Peripheral blood CTL  
S1PR5 1.94E+00 4.14E-82 Peripheral blood CTL ◁ 
CX3CR1 1.64E+00 1.31E-67 Peripheral blood CTL  
CCL5 9.36E-01 1.64E-66 Peripheral blood CTL ✸ 
TBX21 1.28E+00 3.71E-64 Peripheral blood CTL ◉ 
FGR 1.55E+00 1.96E-58 Peripheral blood CTL  
FGFBP2 1.77E+00 1.38E-57 Peripheral blood CTL  
EFHD2 1.36E+00 2.61E-56 Peripheral blood CTL  
TRGC2 1.57E+00 1.10E-54 Peripheral blood CTL  
FCRL6 1.33E+00 1.87E-51 Peripheral blood CTL  
FCGR3A 1.52E+00 5.86E-49 Peripheral blood CTL ◁ 
PLEK 1.40E+00 1.11E-45 Peripheral blood CTL ◉ 
CST7 1.05E+00 1.28E-43 Peripheral blood CTL  
ITGB2 9.32E-01 1.20E-42 Peripheral blood CTL  
GZMA 1.48E+00 2.84E-42 Peripheral blood CTL  
FLVCR2 5.21E-01 4.90E-38 Peripheral blood CTL  
PRSS23 1.20E+00 1.63E-35 Peripheral blood CTL  
CTSW 1.06E+00 3.00E-35 Peripheral blood CTL ✘ 
CCL4 1.26E+00 1.35E-34 Peripheral blood CTL ✸ 
ADRB2 1.23E+00 7.44E-33 Peripheral blood CTL  
PFN1P1 2.53E-01 4.83E-32 Peripheral blood CTL  
SPON2 1.38E+00 9.60E-31 Peripheral blood CTL  
KLRD1 1.15E+00 2.67E-29 Peripheral blood CTL  
TRGC1 7.60E-01 3.39E-29 Peripheral blood CTL  
FLNA 8.16E-01 1.63E-28 Peripheral blood CTL  
ARL4C 9.80E-01 2.40E-28 Peripheral blood CTL  
SYT8 5.63E-01 1.40E-24 Peripheral blood CTL  
SYNE2 7.85E-01 8.38E-23 Peripheral blood CTL  


















Compartment Cell type Gene 
annotation 
ASCL2 6.95E-01 5.10E-22 Peripheral blood CTL ◉ 
LITAF 8.27E-01 3.08E-21 Peripheral blood CTL  
ZNF683 1.05E+00 8.94E-21 Peripheral blood CTL ◉ 
EOMES 9.51E-01 1.39E-20 Peripheral blood CTL ◉ 
SAMD3 9.49E-01 2.17E-19 Peripheral blood CTL  
HOPX 1.21E+00 9.28E-19 Peripheral blood CTL ◉ 
RAP1GAP2 6.39E-01 9.66E-19 Peripheral blood CTL  
SH3BGRL3 5.61E-01 2.03E-18 Peripheral blood CTL  
TXNIP 6.02E-01 4.08E-18 Peripheral blood CTL  
C1orf21 8.99E-01 1.12E-17 Peripheral blood CTL  
SLC9A3R1 6.93E-01 1.81E-17 Peripheral blood CTL  
CD8A 8.40E-01 1.90E-17 Peripheral blood CTL  
C12orf75 1.14E+00 2.26E-17 Peripheral blood CTL  
SLC15A4 9.25E-01 3.17E-17 Peripheral blood CTL  
PXN 9.43E-01 1.53E-16 Peripheral blood CTL  
HLA.C 4.72E-01 1.05E-15 Peripheral blood CTL  
MYO1F 7.75E-01 1.62E-15 Peripheral blood CTL  
EMP3 3.90E-01 3.20E-14 Peripheral blood CTL  
PPP2R5C 6.39E-01 4.80E-14 Peripheral blood CTL  
RAP2A 7.15E-01 5.89E-14 Peripheral blood CTL  
HLA.A 4.74E-01 1.03E-13 Peripheral blood CTL  
AHNAK 8.24E-01 1.09E-13 Peripheral blood CTL  
TSPAN32 9.25E-01 1.30E-13 Peripheral blood CTL  
CMC1 1.01E+00 2.60E-13 Peripheral blood CTL  
PATL2 9.03E-01 3.22E-13 Peripheral blood CTL  
ITGAM 6.97E-01 4.74E-13 Peripheral blood CTL  
KLRG1 8.36E-01 6.85E-13 Peripheral blood CTL  
HLA.DPB1 9.00E-01 1.08E-12 Peripheral blood CTL  
LCP1 6.13E-01 1.48E-12 Peripheral blood CTL  
HCST 7.18E-01 1.71E-12 Peripheral blood CTL  
CCND3 5.59E-01 2.45E-12 Peripheral blood CTL  
APOBEC3G 8.46E-01 2.52E-12 Peripheral blood CTL  
KLRF1 9.54E-01 4.13E-12 Peripheral blood CTL  
PDGFD 5.94E-01 8.70E-12 Peripheral blood CTL ✸ 
ZFP36L2 4.43E-01 1.05E-11 Peripheral blood CTL ◉ 
SLC20A1 7.61E-01 1.18E-11 Peripheral blood CTL  
CLIC3 8.00E-01 1.32E-11 Peripheral blood CTL  
RASSF1 7.47E-01 4.48E-11 Peripheral blood CTL  
PYHIN1 8.95E-01 4.91E-11 Peripheral blood CTL  


















Compartment Cell type Gene 
annotation 
RP11.81H14.2 5.22E-01 1.08E-10 Peripheral blood CTL  
NCR1 3.79E-01 3.05E-10 Peripheral blood CTL  
LPCAT1 5.39E-01 4.17E-10 Peripheral blood CTL  
TPST2 6.94E-01 8.86E-10 Peripheral blood CTL  
USP28 4.99E-01 1.04E-09 Peripheral blood CTL  
CD8B 4.52E-01 1.34E-09 Peripheral blood CTL  
CD300A 7.72E-01 2.28E-09 Peripheral blood CTL  
RUNX3 7.44E-01 2.32E-09 Peripheral blood CTL ◉ 
CYTH4 6.20E-01 2.60E-09 Peripheral blood CTL  
MAPK1 7.73E-01 2.87E-09 Peripheral blood CTL  
LYAR 9.36E-01 4.91E-09 Peripheral blood CTL  
PTGDR 8.27E-01 5.28E-09 Peripheral blood CTL  
ID2 6.69E-01 1.13E-08 Peripheral blood CTL ◉ 
TOB1 3.65E-01 1.31E-08 Peripheral blood CTL  
APOBEC3C 3.89E-01 2.11E-08 Peripheral blood CTL  
VCL 6.67E-01 2.14E-08 Peripheral blood CTL  
SYNE1 6.98E-01 2.38E-08 Peripheral blood CTL  
ZNF276 5.07E-01 2.90E-08 Peripheral blood CTL ◉ 
PLAC8 6.36E-01 4.02E-08 Peripheral blood CTL  
ITGAX 7.69E-01 5.67E-08 Peripheral blood CTL  
ITGAL 6.07E-01 7.06E-08 Peripheral blood CTL  
MED15 5.38E-01 8.56E-08 Peripheral blood CTL  
RAP2B 3.85E-01 9.63E-08 Peripheral blood CTL  
SLAMF6 5.69E-01 1.02E-07 Peripheral blood CTL  
PRR5L 8.09E-01 1.05E-07 Peripheral blood CTL  
C9orf142 6.06E-01 1.42E-07 Peripheral blood CTL  
LSP1 4.45E-01 1.49E-07 Peripheral blood CTL ✘ 
TGFBR3 5.09E-01 1.70E-07 Peripheral blood CTL  
ANXA2 6.52E-01 1.70E-07 Peripheral blood CTL  
MYO1G 4.95E-01 1.76E-07 Peripheral blood CTL  
KRT72 4.31E-01 2.56E-07 Peripheral blood CTL  
CTBP1 4.43E-01 2.88E-07 Peripheral blood CTL  
OSBPL5 3.95E-01 3.63E-07 Peripheral blood CTL  
ARHGAP25 6.05E-01 3.91E-07 Peripheral blood CTL  
SERPINB6 7.05E-01 4.64E-07 Peripheral blood CTL  
MBP 7.13E-01 5.55E-07 Peripheral blood CTL  
TLN1 6.48E-01 5.72E-07 Peripheral blood CTL  
SLAMF7 5.50E-01 6.36E-07 Peripheral blood CTL  
CFL1 3.03E-01 6.43E-07 Peripheral blood CTL  


















Compartment Cell type Gene 
annotation 
LILRB1 5.59E-01 7.93E-07 Peripheral blood CTL  
S1PR1 6.45E-01 7.96E-07 Peripheral blood CTL ◁ 
RNF166 3.85E-01 1.44E-06 Peripheral blood CTL ◉ 
SH2D1A 6.52E-01 1.46E-06 Peripheral blood CTL  
JAKMIP1 4.57E-01 1.58E-06 Peripheral blood CTL  
CCL3 3.71E-01 1.76E-06 Peripheral blood CTL ✸ 
UCP2 5.41E-01 1.79E-06 Peripheral blood CTL  
HLA.B 3.39E-01 2.25E-06 Peripheral blood CTL  
ARRDC3 2.85E-01 2.66E-06 Peripheral blood CTL  
ADGRE5 6.15E-01 2.81E-06 Peripheral blood CTL  
APMAP 6.46E-01 4.76E-06 Peripheral blood CTL  
PREX1 3.87E-01 5.17E-06 Peripheral blood CTL  
CLIC1 5.10E-01 5.76E-06 Peripheral blood CTL  
H6PD 3.70E-01 6.76E-06 Peripheral blood CTL  
ADAP1 5.15E-01 6.96E-06 Peripheral blood CTL  
CHST12 5.31E-01 7.11E-06 Peripheral blood CTL  
FAM49A 5.32E-01 7.18E-06 Peripheral blood CTL  
MRFAP1L1 5.27E-01 7.47E-06 Peripheral blood CTL  
STARD3NL 6.37E-01 8.76E-06 Peripheral blood CTL  
CYBA 5.36E-01 8.83E-06 Peripheral blood CTL  
PARP8 3.91E-01 9.71E-06 Peripheral blood CTL  
MATK 6.05E-01 9.90E-06 Peripheral blood CTL  
CMKLR1 3.10E-01 1.19E-05 Peripheral blood CTL  
CD99 5.20E-01 1.38E-05 Peripheral blood CTL  
FCRL3 4.54E-01 1.49E-05 Peripheral blood CTL  
S100A4 5.82E-01 2.45E-05 Peripheral blood CTL  
STK38 6.01E-01 2.61E-05 Peripheral blood CTL  
ARRB2 3.67E-01 3.14E-05 Peripheral blood CTL  
MYL6 3.46E-01 3.67E-05 Peripheral blood CTL  
FBXW5 5.10E-01 4.19E-05 Peripheral blood CTL  
LGR6 3.04E-01 5.76E-05 Peripheral blood CTL  
GNAI2 6.15E-01 6.63E-05 Peripheral blood CTL  
PRMT2 3.28E-01 6.89E-05 Peripheral blood CTL  
TYROBP 7.17E-01 7.66E-05 Peripheral blood CTL  
ABI3 4.90E-01 8.59E-05 Peripheral blood CTL  
HCLS1 4.12E-01 9.20E-05 Peripheral blood CTL  
TFEB 4.55E-01 9.88E-05 Peripheral blood CTL ◉ 
PTPRC 3.98E-01 1.07E-04 Peripheral blood CTL ✘ 
CDC25B 3.44E-01 1.07E-04 Peripheral blood CTL  


















Compartment Cell type Gene 
annotation 
SELPLG 3.53E-01 1.11E-04 Peripheral blood CTL  
DGKZ 3.95E-01 1.28E-04 Peripheral blood CTL  
TES 4.89E-01 1.31E-04 Peripheral blood CTL  
CEP78 6.67E-01 1.40E-04 Peripheral blood CTL  
STAT6 4.51E-01 1.48E-04 Peripheral blood CTL ◉ 
TTC38 6.77E-01 1.63E-04 Peripheral blood CTL  
KCNAB2 7.16E-01 2.38E-04 Peripheral blood CTL  
NLRP1 4.91E-01 2.44E-04 Peripheral blood CTL  
FUT11 6.25E-01 2.70E-04 Peripheral blood CTL  
MYBL1 5.47E-01 2.79E-04 Peripheral blood CTL ◉ 
MSN 5.99E-01 2.79E-04 Peripheral blood CTL  
CD52 3.09E-01 2.79E-04 Peripheral blood CTL  
UQCRB 4.26E-01 4.42E-04 Peripheral blood CTL  
SEPT7 5.15E-01 4.48E-04 Peripheral blood CTL  
CDKN2D 6.33E-01 5.90E-04 Peripheral blood CTL  
HNRNPD 3.12E-01 7.07E-04 Peripheral blood CTL  
BTN3A2 3.10E-01 8.20E-04 Peripheral blood CTL  
CYTOR 2.67E-01 8.53E-04 Peripheral blood CTL  
CASP8 6.50E-01 8.95E-04 Peripheral blood CTL  
CD63 5.35E-01 9.97E-04 Peripheral blood CTL  
FADS2 3.98E-01 1.06E-03 Peripheral blood CTL  
AKNA 5.57E-01 1.28E-03 Peripheral blood CTL ◉ 
RASA3 5.11E-01 1.30E-03 Peripheral blood CTL  
DPP7 3.20E-01 1.37E-03 Peripheral blood CTL  
LLGL2 4.21E-01 1.39E-03 Peripheral blood CTL  
NPRL2 5.11E-01 1.39E-03 Peripheral blood CTL  
PSMB8 4.32E-01 1.40E-03 Peripheral blood CTL  
ADAM8 3.64E-01 1.70E-03 Peripheral blood CTL  
PRKCB 4.20E-01 1.97E-03 Peripheral blood CTL ✘ ◁ 
STK10 5.37E-01 2.11E-03 Peripheral blood CTL  
S100A10 4.09E-01 2.49E-03 Peripheral blood CTL  
RHOA 3.43E-01 2.55E-03 Peripheral blood CTL  
ANKRD36BP1 3.31E-01 2.71E-03 Peripheral blood CTL  
ZAP70 4.27E-01 2.84E-03 Peripheral blood CTL  
DSTN 3.42E-01 3.08E-03 Peripheral blood CTL  
PRELID1 4.10E-01 3.28E-03 Peripheral blood CTL  
PTP4A2 3.61E-01 3.98E-03 Peripheral blood CTL  
DLG5 3.29E-01 4.38E-03 Peripheral blood CTL  
SAMHD1 2.98E-01 5.31E-03 Peripheral blood CTL  


















Compartment Cell type Gene 
annotation 
GSE1 3.72E-01 5.59E-03 Peripheral blood CTL  
ARPC5L 4.34E-01 6.59E-03 Peripheral blood CTL  
MIR4435.2HG 3.80E-01 6.86E-03 Peripheral blood CTL  
LYPLA2 3.00E-01 7.59E-03 Peripheral blood CTL  
MTATP6P1 3.80E-01 9.73E-03 Peripheral blood CTL  
ARHGAP30 3.22E-01 1.04E-02 Peripheral blood CTL  
PGAM1 3.34E-01 1.15E-02 Peripheral blood CTL  
SLC25A20 4.36E-01 1.16E-02 Peripheral blood CTL  
CYTH1 3.06E-01 1.17E-02 Peripheral blood CTL  
RNF213 2.69E-01 1.17E-02 Peripheral blood CTL  
SYTL1 5.87E-01 1.32E-02 Peripheral blood CTL  
GAB3 5.56E-01 1.38E-02 Peripheral blood CTL  
ACTB 2.86E-01 1.47E-02 Peripheral blood CTL  
TPM3 4.14E-01 1.54E-02 Peripheral blood CTL  
ATM 3.20E-01 1.58E-02 Peripheral blood CTL  
BROX 2.70E-01 1.66E-02 Peripheral blood CTL  
TTC16 5.03E-01 1.73E-02 Peripheral blood CTL  
STX10 4.71E-01 1.88E-02 Peripheral blood CTL  
PIK3R5 4.01E-01 1.94E-02 Peripheral blood CTL  
ARHGEF1 3.85E-01 1.96E-02 Peripheral blood CTL  
CAPN2 4.79E-01 1.97E-02 Peripheral blood CTL  
MTND4P12 2.70E-01 2.08E-02 Peripheral blood CTL  
PRKCH 3.21E-01 2.47E-02 Peripheral blood CTL ◁ 
FAM65B 3.11E-01 2.63E-02 Peripheral blood CTL  
STARD7 4.03E-01 2.75E-02 Peripheral blood CTL  
IL2RB 4.62E-01 2.78E-02 Peripheral blood CTL ◁ 
MOB3A 3.54E-01 2.93E-02 Peripheral blood CTL  
ACTN4 5.91E-01 3.02E-02 Peripheral blood CTL  
SLC2A1 4.24E-01 3.22E-02 Peripheral blood CTL  
F2R 3.31E-01 3.40E-02 Peripheral blood CTL  
FAM49B 4.98E-01 3.78E-02 Peripheral blood CTL  
ANKRD20A11P 2.99E-01 4.46E-02 Peripheral blood CTL  
RGS9 3.54E-01 4.52E-02 Peripheral blood CTL ◉ 
RPS27L 3.91E-01 4.65E-02 Peripheral blood CTL  
C11orf21 4.50E-01 4.68E-02 Peripheral blood CTL  
TAF10 4.29E-01 4.70E-02 Peripheral blood CTL  
CCL5 1.14E+00 1.70E-120 Intestinal mucosa CTL ✸ 
CD160 1.51E+00 3.82E-70 Intestinal mucosa CTL  
TMSB4XP8 4.07E-01 3.00E-51 Intestinal mucosa CTL  


















Compartment Cell type Gene 
annotation 
XCL1 5.67E-01 4.30E-42 Intestinal mucosa CTL ✸ 
XCL2 7.25E-01 9.84E-42 Intestinal mucosa CTL ✸ 
CD8A 1.06E+00 2.59E-40 Intestinal mucosa CTL  
ITGA1 8.30E-01 9.88E-40 Intestinal mucosa CTL  
CKLF 8.62E-01 8.94E-38 Intestinal mucosa CTL ✸ 
TMSB4X 2.84E-01 6.70E-35 Intestinal mucosa CTL  
OSTF1 6.24E-01 3.04E-34 Intestinal mucosa CTL  
CD3G 3.80E-01 5.68E-34 Intestinal mucosa CTL ◁ 
RNF122 3.92E-01 2.21E-33 Intestinal mucosa CTL  
PDCD4 5.63E-01 8.45E-33 Intestinal mucosa CTL  
PLEKHF1 9.59E-01 1.23E-30 Intestinal mucosa CTL  
CAPG 7.33E-01 4.69E-29 Intestinal mucosa CTL  
CD2 7.03E-01 3.48E-27 Intestinal mucosa CTL  
TMIGD2 8.13E-01 1.49E-26 Intestinal mucosa CTL  
ITM2C 9.05E-01 4.59E-26 Intestinal mucosa CTL  
STK17B 3.61E-01 3.95E-25 Intestinal mucosa CTL  
CDV3 6.28E-01 1.38E-24 Intestinal mucosa CTL  
STOM 8.13E-01 1.40E-24 Intestinal mucosa CTL  
ABI3 9.20E-01 1.18E-22 Intestinal mucosa CTL  
ITGAE 7.97E-01 6.31E-21 Intestinal mucosa CTL ◁ 
CD8B 8.02E-01 3.58E-20 Intestinal mucosa CTL  
ALOX5AP 7.42E-01 7.43E-20 Intestinal mucosa CTL  
RGL4 7.22E-01 2.34E-19 Intestinal mucosa CTL  
CD3D 5.01E-01 4.40E-19 Intestinal mucosa CTL ◁ 
SMURF2 6.71E-01 9.98E-19 Intestinal mucosa CTL  
PIP4K2A 2.95E-01 1.05E-18 Intestinal mucosa CTL  
MBOAT1 4.94E-01 1.66E-17 Intestinal mucosa CTL  
NMUR1 5.68E-01 3.30E-17 Intestinal mucosa CTL  
PSD4 5.64E-01 1.03E-16 Intestinal mucosa CTL  
PTPN22 6.44E-01 3.55E-16 Intestinal mucosa CTL ✘ 
SCUBE1 4.85E-01 3.77E-16 Intestinal mucosa CTL  
ABCA1 6.83E-01 3.94E-16 Intestinal mucosa CTL  
CAPZA1 2.86E-01 3.11E-14 Intestinal mucosa CTL  
MIAT 6.52E-01 1.73E-13 Intestinal mucosa CTL  
CCR9 4.96E-01 5.88E-13 Intestinal mucosa CTL ◁ 
CXCR6 8.95E-01 6.63E-13 Intestinal mucosa CTL  
CTC.425F1.4 3.26E-01 1.90E-12 Intestinal mucosa CTL  
SLAMF7 7.15E-01 2.28E-12 Intestinal mucosa CTL  
TLE3 4.26E-01 3.52E-12 Intestinal mucosa CTL  


















Compartment Cell type Gene 
annotation 
RP11.94L15.2 6.82E-01 2.13E-11 Intestinal mucosa CTL  
SAR1A 2.89E-01 4.62E-11 Intestinal mucosa CTL  
DENND2D 4.37E-01 6.73E-11 Intestinal mucosa CTL  
COTL1 5.56E-01 1.49E-10 Intestinal mucosa CTL  
MDM4 4.08E-01 6.94E-10 Intestinal mucosa CTL  
JAML 5.38E-01 7.68E-10 Intestinal mucosa CTL  
SLC7A8 3.36E-01 9.89E-10 Intestinal mucosa CTL  
CYBA 3.42E-01 1.25E-09 Intestinal mucosa CTL  
AUTS2 4.64E-01 2.15E-09 Intestinal mucosa CTL  
CALR 2.61E-01 7.04E-09 Intestinal mucosa CTL  
AFAP1L2 3.57E-01 9.01E-09 Intestinal mucosa CTL  
TBL1XR1 3.72E-01 1.20E-08 Intestinal mucosa CTL  
CD3E 3.21E-01 1.93E-08 Intestinal mucosa CTL ◁ 
RHOC 6.53E-01 1.99E-08 Intestinal mucosa CTL  
CD244 4.98E-01 2.06E-08 Intestinal mucosa CTL  
DAPK2 5.92E-01 2.83E-08 Intestinal mucosa CTL  
TRAC 3.19E-01 2.98E-08 Intestinal mucosa CTL  
CD96 3.60E-01 4.43E-08 Intestinal mucosa CTL  
KLRB1 3.78E-01 5.35E-08 Intestinal mucosa CTL  
MIDN 4.30E-01 2.67E-07 Intestinal mucosa CTL  
YWHAH 6.03E-01 5.21E-07 Intestinal mucosa CTL  
AC092580.4 5.70E-01 5.41E-07 Intestinal mucosa CTL  
SEPT1 3.04E-01 1.41E-06 Intestinal mucosa CTL  
PPP3CA 3.09E-01 1.48E-06 Intestinal mucosa CTL  
FASLG 6.39E-01 8.39E-06 Intestinal mucosa CTL ✸ 
CD248 3.08E-01 9.99E-06 Intestinal mucosa CTL  
TMEM120B 3.22E-01 1.37E-05 Intestinal mucosa CTL  
GAB3 3.92E-01 1.62E-05 Intestinal mucosa CTL  
TGFBR1 5.06E-01 2.58E-05 Intestinal mucosa CTL  
CTD.2369P2.2 2.68E-01 3.63E-05 Intestinal mucosa CTL  
SBNO1 3.46E-01 3.81E-05 Intestinal mucosa CTL  
FMNL3 2.68E-01 4.74E-05 Intestinal mucosa CTL  
ERO1A 3.54E-01 4.88E-05 Intestinal mucosa CTL  
PSME2 3.69E-01 5.49E-05 Intestinal mucosa CTL  
CD101 4.68E-01 6.47E-05 Intestinal mucosa CTL  
TRGC1 2.72E-01 7.17E-05 Intestinal mucosa CTL  
TTI2 3.61E-01 9.01E-05 Intestinal mucosa CTL  
RP11.841O20.2 3.57E-01 1.03E-04 Intestinal mucosa CTL  
FKBP1A 4.29E-01 1.07E-04 Intestinal mucosa CTL ◁ 


















Compartment Cell type Gene 
annotation 
BUB3 2.53E-01 1.28E-04 Intestinal mucosa CTL  
FYN 3.77E-01 1.60E-04 Intestinal mucosa CTL  
LAG3 3.12E-01 1.65E-04 Intestinal mucosa CTL  
RHOF 2.87E-01 2.25E-04 Intestinal mucosa CTL  
CEPT1 2.56E-01 2.38E-04 Intestinal mucosa CTL  
TMEM33 3.38E-01 2.57E-04 Intestinal mucosa CTL  
FNBP1 3.28E-01 2.93E-04 Intestinal mucosa CTL  
IL18RAP 3.44E-01 3.06E-04 Intestinal mucosa CTL  
GUK1 3.39E-01 3.24E-04 Intestinal mucosa CTL  
AP1G1 2.89E-01 4.20E-04 Intestinal mucosa CTL  
TRGC2 5.15E-01 4.26E-04 Intestinal mucosa CTL  
ST3GAL5 3.32E-01 4.88E-04 Intestinal mucosa CTL  
KLRC1 3.54E-01 5.28E-04 Intestinal mucosa CTL  
DNAJC3 3.57E-01 6.14E-04 Intestinal mucosa CTL  
SLC35F6 3.29E-01 6.31E-04 Intestinal mucosa CTL  
GPR82 3.60E-01 6.73E-04 Intestinal mucosa CTL  
DTX3L 4.27E-01 7.17E-04 Intestinal mucosa CTL  
CD63 5.61E-01 9.29E-04 Intestinal mucosa CTL  
AP4B1 3.02E-01 9.53E-04 Intestinal mucosa CTL  
PTPN6 2.93E-01 1.20E-03 Intestinal mucosa CTL  
TROVE2 2.87E-01 1.49E-03 Intestinal mucosa CTL  
EIF1AD 3.55E-01 1.54E-03 Intestinal mucosa CTL  
C9orf78 4.05E-01 2.44E-03 Intestinal mucosa CTL  
PARP9 3.83E-01 3.13E-03 Intestinal mucosa CTL  
PLCG2 3.43E-01 4.57E-03 Intestinal mucosa CTL ✘ 
TMED2 3.23E-01 4.82E-03 Intestinal mucosa CTL  
SPN 3.05E-01 5.05E-03 Intestinal mucosa CTL  
FYCO1 2.60E-01 5.27E-03 Intestinal mucosa CTL  
XYLT2 2.86E-01 5.65E-03 Intestinal mucosa CTL  
AC020571.3 5.17E-01 5.86E-03 Intestinal mucosa CTL  
DHRS7 4.46E-01 7.16E-03 Intestinal mucosa CTL  
WDR41 4.20E-01 7.48E-03 Intestinal mucosa CTL  
CD9 5.51E-01 8.02E-03 Intestinal mucosa CTL  
TAPBP 2.81E-01 9.49E-03 Intestinal mucosa CTL  
SOCS1 3.59E-01 9.51E-03 Intestinal mucosa CTL ✘ 
ZSWIM1 3.15E-01 1.02E-02 Intestinal mucosa CTL  
TNFSF14 4.70E-01 1.16E-02 Intestinal mucosa CTL ✸ 
PSMA3 2.89E-01 1.21E-02 Intestinal mucosa CTL  
ANAPC11 4.20E-01 1.70E-02 Intestinal mucosa CTL  


















Compartment Cell type Gene 
annotation 
GYG1 5.52E-01 1.86E-02 Intestinal mucosa CTL  
GNGT2 4.30E-01 2.03E-02 Intestinal mucosa CTL  
PDIA3 2.79E-01 2.91E-02 Intestinal mucosa CTL  
MAN1A1 2.90E-01 3.13E-02 Intestinal mucosa CTL  
GSTP1 4.04E-01 3.50E-02 Intestinal mucosa CTL  
NOP10 2.90E-01 3.75E-02 Intestinal mucosa CTL  
MARCH2 3.11E-01 4.57E-02 Intestinal mucosa CTL  
DOCK5 3.62E-01 4.63E-02 Intestinal mucosa CTL  
SELL 1.17E+00 3.05E-97 Peripheral blood Quiescent  
CCR7 1.02E+00 5.98E-85 Peripheral blood Quiescent  
NOG 1.22E+00 5.86E-72 Peripheral blood Quiescent  
RP11.360D2.2 4.65E-01 7.01E-64 Peripheral blood Quiescent  
RP11.234A1.1 3.96E-01 6.32E-59 Peripheral blood Quiescent  
RP4.765C7.2 3.47E-01 2.27E-57 Peripheral blood Quiescent  
RPS27 3.81E-01 9.92E-57 Peripheral blood Quiescent  
RPS14P3 3.66E-01 1.43E-55 Peripheral blood Quiescent  
RP11.543P15.1 2.89E-01 4.01E-53 Peripheral blood Quiescent  
FAM65B 5.63E-01 1.78E-40 Peripheral blood Quiescent  
C16orf54 4.27E-01 1.47E-38 Peripheral blood Quiescent  
RPL34 3.88E-01 5.75E-37 Peripheral blood Quiescent  
RPS14 3.10E-01 4.93E-36 Peripheral blood Quiescent  
PCED1B.AS1 6.89E-01 1.32E-34 Peripheral blood Quiescent  
RPL18A 3.17E-01 2.83E-34 Peripheral blood Quiescent  
RPL3P4 3.10E-01 5.68E-34 Peripheral blood Quiescent  
RPS25 3.60E-01 6.06E-34 Peripheral blood Quiescent  
CDC42SE1 2.91E-01 2.47E-32 Peripheral blood Quiescent  
RPS18 3.27E-01 3.76E-31 Peripheral blood Quiescent  
RPL31 4.80E-01 1.59E-30 Peripheral blood Quiescent  
RPS28 4.60E-01 1.21E-29 Peripheral blood Quiescent  
RPL3 2.83E-01 1.49E-29 Peripheral blood Quiescent  
C1orf56 2.92E-01 4.64E-28 Peripheral blood Quiescent  
MYC 6.89E-01 2.67E-27 Peripheral blood Quiescent ◉ 
RPL23A 3.46E-01 3.09E-27 Peripheral blood Quiescent  
NOSIP 6.46E-01 4.69E-27 Peripheral blood Quiescent  
RP4.594I10.3 4.94E-01 6.23E-27 Peripheral blood Quiescent  
TMSB10 3.17E-01 1.23E-26 Peripheral blood Quiescent  
RCAN3 5.23E-01 1.94E-26 Peripheral blood Quiescent  
RPS6 3.42E-01 7.94E-26 Peripheral blood Quiescent  
RPL13A 3.40E-01 1.32E-24 Peripheral blood Quiescent  


















Compartment Cell type Gene 
annotation 
RPS15 4.14E-01 1.02E-23 Peripheral blood Quiescent  
RPL32 4.24E-01 2.28E-23 Peripheral blood Quiescent  
RPS11 2.84E-01 2.76E-23 Peripheral blood Quiescent  
RPL37A 4.97E-01 2.98E-23 Peripheral blood Quiescent  
RPL23 3.40E-01 7.86E-23 Peripheral blood Quiescent  
RPS29 4.15E-01 1.81E-22 Peripheral blood Quiescent  
RPL10P3 4.05E-01 6.72E-22 Peripheral blood Quiescent  
LDHB 5.55E-01 2.62E-20 Peripheral blood Quiescent  
IL6ST 4.22E-01 3.06E-20 Peripheral blood Quiescent ✸ 
AES 3.82E-01 6.01E-20 Peripheral blood Quiescent  
RPL13 3.01E-01 9.98E-20 Peripheral blood Quiescent  
RPL30 4.69E-01 4.54E-19 Peripheral blood Quiescent  
GIMAP7 3.68E-01 1.88E-18 Peripheral blood Quiescent  
TRABD2A 5.92E-01 4.56E-18 Peripheral blood Quiescent  
RPS3 3.16E-01 5.59E-18 Peripheral blood Quiescent  
RPS28P7 3.84E-01 7.57E-18 Peripheral blood Quiescent  
RPS13 4.57E-01 9.73E-18 Peripheral blood Quiescent  
RPS21 4.48E-01 9.78E-18 Peripheral blood Quiescent  
LINC00861 5.82E-01 5.17E-17 Peripheral blood Quiescent  
MDS2 5.25E-01 1.18E-16 Peripheral blood Quiescent  
RPL5 4.58E-01 1.90E-16 Peripheral blood Quiescent  
RASSF3 3.72E-01 3.96E-15 Peripheral blood Quiescent  
EIF2S3 3.18E-01 2.67E-14 Peripheral blood Quiescent  
LIMD2 3.14E-01 4.62E-14 Peripheral blood Quiescent  
RPL27A 3.37E-01 5.34E-14 Peripheral blood Quiescent  
RPL19 3.82E-01 7.94E-14 Peripheral blood Quiescent  
RPL15 2.99E-01 1.27E-13 Peripheral blood Quiescent  
RPS16 3.56E-01 1.41E-13 Peripheral blood Quiescent  
TOB1 4.13E-01 1.48E-13 Peripheral blood Quiescent  
RPS12 3.85E-01 1.70E-13 Peripheral blood Quiescent  
RPL14 3.64E-01 2.80E-13 Peripheral blood Quiescent  
RPL39 3.63E-01 3.23E-13 Peripheral blood Quiescent  
RPL28 3.93E-01 3.28E-13 Peripheral blood Quiescent  
RPL11 4.53E-01 3.56E-13 Peripheral blood Quiescent  
RPL27 3.39E-01 4.00E-13 Peripheral blood Quiescent  
TCF7 3.73E-01 4.05E-13 Peripheral blood Quiescent ◉ 
RP11.415F23.2 4.99E-01 5.53E-13 Peripheral blood Quiescent  
AC005944.2 4.02E-01 1.64E-12 Peripheral blood Quiescent  
RPL9 2.85E-01 1.80E-12 Peripheral blood Quiescent  


















Compartment Cell type Gene 
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CD27 3.79E-01 9.01E-12 Peripheral blood Quiescent  
RPS20 3.03E-01 1.13E-11 Peripheral blood Quiescent  
CTD.2031P19.5 2.70E-01 1.39E-11 Peripheral blood Quiescent  
RPL38 4.09E-01 1.39E-11 Peripheral blood Quiescent  
RPL10A 3.15E-01 1.53E-11 Peripheral blood Quiescent  
LRRC75A.AS1 4.46E-01 2.57E-11 Peripheral blood Quiescent  
FOXP1 3.25E-01 2.75E-11 Peripheral blood Quiescent ◉ 
S1PR1 5.11E-01 3.03E-11 Peripheral blood Quiescent ◁ 
RPL26 3.76E-01 3.69E-11 Peripheral blood Quiescent  
RPS15A 3.75E-01 6.71E-11 Peripheral blood Quiescent  
RACK1 4.12E-01 7.37E-11 Peripheral blood Quiescent  
RASGRP2 3.59E-01 1.32E-10 Peripheral blood Quiescent  
RPLP2 3.16E-01 1.32E-10 Peripheral blood Quiescent  
LRRC75A 4.33E-01 1.38E-10 Peripheral blood Quiescent  
TXNIP 3.87E-01 1.58E-10 Peripheral blood Quiescent  
PRKCA 5.04E-01 2.38E-10 Peripheral blood Quiescent ◁ 
EIF4B 3.07E-01 2.43E-10 Peripheral blood Quiescent  
RPL36 2.82E-01 3.66E-10 Peripheral blood Quiescent  
RPS27A 2.80E-01 5.51E-10 Peripheral blood Quiescent  
LDLRAP1 4.77E-01 5.52E-10 Peripheral blood Quiescent  
C1orf162 5.86E-01 1.04E-09 Peripheral blood Quiescent  
PIK3IP1 4.53E-01 2.67E-09 Peripheral blood Quiescent  
DENND5A 3.80E-01 2.82E-09 Peripheral blood Quiescent  
ADTRP 5.80E-01 5.46E-09 Peripheral blood Quiescent  
RPL18 3.29E-01 8.19E-09 Peripheral blood Quiescent  
RP4.635E18.8 3.91E-01 1.35E-08 Peripheral blood Quiescent  
RP11.252A24.7 3.79E-01 1.42E-08 Peripheral blood Quiescent  
RP11.458N5.1 3.88E-01 2.18E-08 Peripheral blood Quiescent  
GAS5 4.47E-01 2.20E-08 Peripheral blood Quiescent  
MAL 6.51E-01 2.91E-08 Peripheral blood Quiescent  
IL7R 2.85E-01 4.34E-08 Peripheral blood Quiescent  
RPS23 3.36E-01 7.98E-08 Peripheral blood Quiescent  
RPL8 2.64E-01 3.56E-07 Peripheral blood Quiescent  
PRKCQ.AS1 5.01E-01 3.81E-07 Peripheral blood Quiescent  
RPS9 3.11E-01 4.72E-07 Peripheral blood Quiescent  
NPM1 2.53E-01 7.45E-07 Peripheral blood Quiescent  
TCEA3 4.72E-01 9.23E-07 Peripheral blood Quiescent  
LINC01089 4.09E-01 9.79E-07 Peripheral blood Quiescent  
PRMT2 3.40E-01 1.12E-06 Peripheral blood Quiescent  


















Compartment Cell type Gene 
annotation 
RPL37 3.65E-01 1.53E-06 Peripheral blood Quiescent  
S100A8 5.75E-01 1.86E-06 Peripheral blood Quiescent  
RPLP0 2.62E-01 2.04E-06 Peripheral blood Quiescent  
RPL12 3.16E-01 2.10E-06 Peripheral blood Quiescent  
FCN1 2.91E-01 2.36E-06 Peripheral blood Quiescent  
PCED1B 5.26E-01 2.38E-06 Peripheral blood Quiescent  
RPL29 3.11E-01 2.58E-06 Peripheral blood Quiescent  
SVIL 3.91E-01 4.87E-06 Peripheral blood Quiescent  
EEF1D 2.92E-01 5.91E-06 Peripheral blood Quiescent  
SATB1 3.90E-01 1.14E-05 Peripheral blood Quiescent ◉ 
ADD3 3.22E-01 1.60E-05 Peripheral blood Quiescent  
GIMAP4 3.17E-01 2.26E-05 Peripheral blood Quiescent  
GLTSCR2 3.43E-01 2.58E-05 Peripheral blood Quiescent  
SNORA12.2 3.27E-01 2.65E-05 Peripheral blood Quiescent  
RP11.434H6.7 4.19E-01 5.27E-05 Peripheral blood Quiescent  
CSF3R 2.53E-01 5.63E-05 Peripheral blood Quiescent ◁ 
RASA3 4.09E-01 7.03E-05 Peripheral blood Quiescent  
RPL7A 2.97E-01 9.90E-05 Peripheral blood Quiescent  
ZNF516 3.29E-01 1.20E-04 Peripheral blood Quiescent ◉ 
SUSD3 3.53E-01 3.48E-04 Peripheral blood Quiescent  
RPS4Y1 4.42E-01 4.10E-04 Peripheral blood Quiescent  
RPS4X 2.59E-01 4.95E-04 Peripheral blood Quiescent  
ITGB2.AS1 2.82E-01 5.50E-04 Peripheral blood Quiescent  
SDK2 2.67E-01 5.71E-04 Peripheral blood Quiescent  
IL16 2.61E-01 6.35E-04 Peripheral blood Quiescent ✸ 
LYZ 5.78E-01 8.54E-04 Peripheral blood Quiescent  
RPS5 3.08E-01 8.55E-04 Peripheral blood Quiescent  
RPARP.AS1 3.44E-01 8.77E-04 Peripheral blood Quiescent  
RPL35A 3.01E-01 1.00E-03 Peripheral blood Quiescent  
TXK 3.42E-01 1.03E-03 Peripheral blood Quiescent  
DSEL 4.16E-01 2.31E-03 Peripheral blood Quiescent  
S100A9 6.25E-01 2.32E-03 Peripheral blood Quiescent  
SLC40A1 2.75E-01 4.04E-03 Peripheral blood Quiescent  
MORC2 3.33E-01 4.93E-03 Peripheral blood Quiescent  
SRSF5 3.26E-01 5.69E-03 Peripheral blood Quiescent  
BTF3 2.87E-01 5.80E-03 Peripheral blood Quiescent  
PCMTD2 2.96E-01 6.22E-03 Peripheral blood Quiescent  
TESPA1 3.02E-01 7.20E-03 Peripheral blood Quiescent  
SORL1 3.19E-01 1.07E-02 Peripheral blood Quiescent  


















Compartment Cell type Gene 
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VCAN 2.53E-01 1.15E-02 Peripheral blood Quiescent  
C10orf95 3.27E-01 1.34E-02 Peripheral blood Quiescent  
RPL22 2.75E-01 1.50E-02 Peripheral blood Quiescent  
ACTN1 2.98E-01 1.70E-02 Peripheral blood Quiescent  
PIAS2 3.47E-01 2.25E-02 Peripheral blood Quiescent  
EXOSC8 3.22E-01 2.48E-02 Peripheral blood Quiescent  
BEX3 4.61E-01 2.52E-02 Peripheral blood Quiescent  
SNHG8 4.14E-01 2.70E-02 Peripheral blood Quiescent  
EIF3L 2.74E-01 3.56E-02 Peripheral blood Quiescent  
FCGRT 3.21E-01 4.16E-02 Peripheral blood Quiescent  
REG1B 1.84E+00 5.02E-94 Intestinal mucosa REG1A/1B  
REG1A 2.11E+00 3.79E-89 Intestinal mucosa REG1A/1B ✸ 
PIGR 1.88E+00 6.63E-83 Intestinal mucosa REG1A/1B  
ANPEP 8.31E-01 2.25E-81 Intestinal mucosa REG1A/1B  
DMBT1 9.04E-01 1.06E-76 Intestinal mucosa REG1A/1B  
APOA1 8.54E-01 9.13E-70 Intestinal mucosa REG1A/1B  
APOC3 5.28E-01 1.40E-68 Intestinal mucosa REG1A/1B  
PHGR1 7.82E-01 4.47E-57 Intestinal mucosa REG1A/1B  
ALDOB 1.17E+00 1.55E-54 Intestinal mucosa REG1A/1B  
SLC15A1 6.94E-01 1.22E-52 Intestinal mucosa REG1A/1B  
FABP1 1.02E+00 5.46E-50 Intestinal mucosa REG1A/1B  
IFI27 3.57E-01 3.94E-37 Intestinal mucosa REG1A/1B  
FABP6 3.47E-01 8.22E-37 Intestinal mucosa REG1A/1B  
FABP2 5.56E-01 1.69E-30 Intestinal mucosa REG1A/1B  
KRT19 3.51E-01 2.18E-29 Intestinal mucosa REG1A/1B  
LGALS4 4.02E-01 2.97E-29 Intestinal mucosa REG1A/1B  
SELENOP 1.08E+00 3.48E-29 Intestinal mucosa REG1A/1B  
EPCAM 3.57E-01 8.27E-26 Intestinal mucosa REG1A/1B  
TSPAN8 5.32E-01 1.21E-25 Intestinal mucosa REG1A/1B  
MUC13 3.14E-01 6.08E-25 Intestinal mucosa REG1A/1B  
APOB 3.70E-01 7.86E-24 Intestinal mucosa REG1A/1B  
RARRES1 2.71E-01 2.02E-23 Intestinal mucosa REG1A/1B  
LGALS3BP 4.42E-01 8.21E-19 Intestinal mucosa REG1A/1B  
HLA.DRA 1.09E+00 1.88E-17 Intestinal mucosa REG1A/1B  
SMIM24 6.08E-01 4.88E-17 Intestinal mucosa REG1A/1B  
SPINK1 5.47E-01 3.82E-14 Intestinal mucosa REG1A/1B  
KRT8 3.29E-01 5.06E-14 Intestinal mucosa REG1A/1B  
TFF3 2.89E-01 3.91E-13 Intestinal mucosa REG1A/1B  
HNF4A 3.23E-01 1.43E-12 Intestinal mucosa REG1A/1B ◉ 


















Compartment Cell type Gene 
annotation 
GOLIM4 2.80E-01 5.38E-12 Intestinal mucosa REG1A/1B  
KRT18 2.63E-01 8.39E-11 Intestinal mucosa REG1A/1B  
SLC6A19 2.66E-01 2.33E-10 Intestinal mucosa REG1A/1B  
HLA.DRB1 5.80E-01 2.24E-09 Intestinal mucosa REG1A/1B  
CCDC152 3.27E-01 2.65E-08 Intestinal mucosa REG1A/1B  
ATP1B1 3.74E-01 3.38E-08 Intestinal mucosa REG1A/1B  
IGHA1 2.63E+00 1.89E-06 Intestinal mucosa REG1A/1B  
CD74 4.92E-01 4.24E-06 Intestinal mucosa REG1A/1B  
LGALS3 5.32E-01 4.52E-06 Intestinal mucosa REG1A/1B  
ALDH2 3.23E-01 1.13E-05 Intestinal mucosa REG1A/1B  
TSPAN3 7.87E-01 2.07E-05 Intestinal mucosa REG1A/1B  
OAT 4.68E-01 3.09E-05 Intestinal mucosa REG1A/1B  
JCHAIN 2.85E+00 4.19E-05 Intestinal mucosa REG1A/1B  
IGHG1 2.50E-01 8.06E-05 Intestinal mucosa REG1A/1B  
GCNT3 3.26E-01 8.95E-05 Intestinal mucosa REG1A/1B  
MS4A10 4.80E-01 1.38E-04 Intestinal mucosa REG1A/1B  
CST3 9.40E-01 1.48E-04 Intestinal mucosa REG1A/1B  
HLA.DPA1 3.73E-01 6.53E-04 Intestinal mucosa REG1A/1B  
ACO2 3.07E-01 2.06E-03 Intestinal mucosa REG1A/1B  
IGKC 1.70E+00 2.22E-03 Intestinal mucosa REG1A/1B  
CTSD 7.31E-01 2.28E-03 Intestinal mucosa REG1A/1B  
TM9SF3 3.32E-01 2.68E-03 Intestinal mucosa REG1A/1B  
IGHA2 1.86E+00 3.12E-03 Intestinal mucosa REG1A/1B  
DDAH1 3.12E-01 3.37E-03 Intestinal mucosa REG1A/1B  
RNF24 1.84E+00 4.40E-03 Intestinal mucosa REG1A/1B  
ENAM 2.07E+00 4.78E-03 Intestinal mucosa REG1A/1B  
STK17B 5.04E-01 1.02E-02 Intestinal mucosa REG1A/1B  
IGLC2 1.23E+00 1.09E-02 Intestinal mucosa REG1A/1B  
MUC2 2.75E-01 1.14E-02 Intestinal mucosa REG1A/1B  
TAPBP 5.61E-01 1.88E-02 Intestinal mucosa REG1A/1B  
ECHS1 6.72E-01 2.22E-02 Intestinal mucosa REG1A/1B  
OLFM4 4.49E-01 4.22E-02 Intestinal mucosa REG1A/1B  
RASGEF1B 2.44E+00 4.33E-294 Intestinal mucosa Th17  
RGS1 2.55E+00 1.69E-247 Intestinal mucosa Th17  
CD69 2.36E+00 1.04E-244 Intestinal mucosa Th17  
TNFAIP3 2.28E+00 4.02E-237 Intestinal mucosa Th17 ✘ 
DUSP2 2.33E+00 4.67E-186 Intestinal mucosa Th17  
DNAJB1 2.22E+00 2.19E-184 Intestinal mucosa Th17  
MIR24.2 1.89E+00 1.40E-150 Intestinal mucosa Th17  


















Compartment Cell type Gene 
annotation 
YPEL5 1.73E+00 5.60E-142 Intestinal mucosa Th17  
FAM46C 1.68E+00 2.10E-106 Intestinal mucosa Th17  
PTGER4 1.67E+00 1.15E-96 Intestinal mucosa Th17 ✘ ◁ 
SIK1 9.65E-01 8.05E-93 Intestinal mucosa Th17  
CYTIP 1.16E+00 1.35E-85 Intestinal mucosa Th17  
CXCR4 1.53E+00 6.82E-79 Intestinal mucosa Th17  
SLC2A3 1.49E+00 1.73E-78 Intestinal mucosa Th17  
HSP90AA1 1.33E+00 5.06E-76 Intestinal mucosa Th17  
PHLDA1 1.63E+00 3.02E-75 Intestinal mucosa Th17  
CREM 1.33E+00 4.48E-73 Intestinal mucosa Th17 ◉ 
PFKFB3 1.26E+00 5.93E-63 Intestinal mucosa Th17  
RGS2 1.69E+00 8.00E-61 Intestinal mucosa Th17  
ZNF331 1.51E+00 2.32E-60 Intestinal mucosa Th17 ◉ 
DUSP5 7.63E-01 4.76E-57 Intestinal mucosa Th17  
TSC22D3 1.23E+00 9.20E-56 Intestinal mucosa Th17 ◉ 
CLEC2D 7.86E-01 2.29E-55 Intestinal mucosa Th17  
SELENOK 1.28E+00 9.48E-55 Intestinal mucosa Th17  
CLK1 8.28E-01 3.30E-50 Intestinal mucosa Th17  
DUSP4 1.18E+00 1.29E-48 Intestinal mucosa Th17  
CSRNP1 1.14E+00 1.89E-45 Intestinal mucosa Th17  
PPP1CB 7.14E-01 4.04E-45 Intestinal mucosa Th17  
PABPC1 8.12E-01 5.78E-44 Intestinal mucosa Th17  
SRGN 8.04E-01 2.30E-43 Intestinal mucosa Th17  
HNRNPLL 9.31E-01 9.65E-43 Intestinal mucosa Th17  
SPRY1 1.39E+00 1.27E-42 Intestinal mucosa Th17  
HSPH1 1.12E+00 2.29E-39 Intestinal mucosa Th17  
KLF6 9.43E-01 1.80E-37 Intestinal mucosa Th17 ◉ 
BIRC3 1.23E+00 1.98E-37 Intestinal mucosa Th17  
FTH1 7.55E-01 3.01E-37 Intestinal mucosa Th17  
PER1 8.30E-01 8.37E-37 Intestinal mucosa Th17  
MPZL3 1.05E+00 7.70E-35 Intestinal mucosa Th17  
THBS1 6.66E-01 9.88E-34 Intestinal mucosa Th17  
KDM6B 7.36E-01 3.01E-33 Intestinal mucosa Th17  
MORF4L2 7.79E-01 5.98E-33 Intestinal mucosa Th17  
ETF1 7.92E-01 2.71E-32 Intestinal mucosa Th17  
DNAJA1 1.14E+00 7.72E-31 Intestinal mucosa Th17  
CDKN1A 8.15E-01 2.44E-30 Intestinal mucosa Th17  
DNAJA4 1.24E+00 6.98E-30 Intestinal mucosa Th17  
DUSP10 5.10E-01 1.84E-29 Intestinal mucosa Th17  
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CD96 1.07E+00 6.39E-28 Intestinal mucosa Th17  
LDLRAD4 1.20E+00 1.35E-27 Intestinal mucosa Th17  
USP36 9.61E-01 5.33E-27 Intestinal mucosa Th17  
STN1 7.47E-01 7.24E-27 Intestinal mucosa Th17  
RANBP2 6.00E-01 2.00E-26 Intestinal mucosa Th17  
ABCA1 9.81E-01 2.35E-26 Intestinal mucosa Th17  
SNORD99 6.28E-01 8.66E-26 Intestinal mucosa Th17  
KMT2E 6.81E-01 1.33E-25 Intestinal mucosa Th17  
ZFP36L2 7.49E-01 1.82E-25 Intestinal mucosa Th17 ◉ 
ZNF250 6.73E-01 2.30E-25 Intestinal mucosa Th17 ◉ 
ZSWIM4 4.11E-01 2.35E-25 Intestinal mucosa Th17  
CCNH 8.71E-01 1.97E-24 Intestinal mucosa Th17  
BCAS2 1.00E+00 4.49E-24 Intestinal mucosa Th17  
VMP1 6.84E-01 1.55E-23 Intestinal mucosa Th17  
EML4 8.37E-01 8.40E-23 Intestinal mucosa Th17  
MAPK1IP1L 6.59E-01 1.43E-22 Intestinal mucosa Th17  
ASB2 7.19E-01 5.20E-22 Intestinal mucosa Th17  
CCL20 7.56E-01 5.46E-22 Intestinal mucosa Th17 ✘✸ 
PMAIP1 8.42E-01 6.61E-22 Intestinal mucosa Th17  
IL22 1.00E+00 4.75E-21 Intestinal mucosa Th17 ✸ 
NAMPT 3.24E-01 1.07E-20 Intestinal mucosa Th17 ✸ 
SAT1 8.17E-01 2.65E-20 Intestinal mucosa Th17  
SDCBP 9.11E-01 4.94E-20 Intestinal mucosa Th17  
RP11.138A9.2 6.81E-01 2.82E-19 Intestinal mucosa Th17  
AC008440.5 2.64E-01 3.08E-19 Intestinal mucosa Th17  
IRF2BP2 7.69E-01 3.36E-19 Intestinal mucosa Th17  
SNHG16 7.47E-01 4.81E-19 Intestinal mucosa Th17  
CD55 7.44E-01 1.47E-18 Intestinal mucosa Th17  
ARL5B 7.57E-01 3.02E-18 Intestinal mucosa Th17  
ADAM19 5.04E-01 1.48E-17 Intestinal mucosa Th17  
RPL21 5.67E-01 2.37E-17 Intestinal mucosa Th17  
PTP4A1 8.26E-01 5.76E-17 Intestinal mucosa Th17  
MBOAT1 6.35E-01 1.28E-16 Intestinal mucosa Th17  
MAP3K8 8.01E-01 2.02E-16 Intestinal mucosa Th17 ✘ 
YWHAZ 4.16E-01 7.91E-16 Intestinal mucosa Th17  
EZR 5.74E-01 1.14E-15 Intestinal mucosa Th17  
FMNL3 5.78E-01 2.05E-15 Intestinal mucosa Th17  
IFRD1 7.10E-01 3.02E-15 Intestinal mucosa Th17  
PDCD4 4.13E-01 3.12E-15 Intestinal mucosa Th17  
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HSP90AB1 7.36E-01 1.22E-14 Intestinal mucosa Th17  
ICOS 8.82E-01 2.59E-14 Intestinal mucosa Th17  
PRMT9 8.69E-01 5.56E-14 Intestinal mucosa Th17  
STAT1 6.65E-01 2.33E-13 Intestinal mucosa Th17 ◉ 
PIM3 7.52E-01 3.22E-13 Intestinal mucosa Th17  
PPP1R15B 5.32E-01 4.10E-12 Intestinal mucosa Th17  
IL17A 1.04E+00 1.10E-11 Intestinal mucosa Th17 ✸ ◁ 
VPS37B 4.82E-01 1.29E-11 Intestinal mucosa Th17  
HSPE1 9.28E-01 1.33E-11 Intestinal mucosa Th17  
IRF4 5.31E-01 2.02E-11 Intestinal mucosa Th17 ✘ ◉ 
RORA 6.06E-01 2.80E-11 Intestinal mucosa Th17 ◉ 
NFE2L2 7.10E-01 3.08E-11 Intestinal mucosa Th17 ◉ 
IFNG 7.86E-01 5.22E-11 Intestinal mucosa Th17 ✘✸ 
HLA.J 3.67E-01 6.82E-11 Intestinal mucosa Th17  
HSPA8 5.68E-01 8.03E-11 Intestinal mucosa Th17  
TSPYL1 4.34E-01 8.10E-11 Intestinal mucosa Th17  
AHSA1 3.97E-01 1.21E-10 Intestinal mucosa Th17  
NUP98 4.89E-01 1.43E-10 Intestinal mucosa Th17  
SRSF3 4.46E-01 1.91E-10 Intestinal mucosa Th17  
CHD1 6.84E-01 2.29E-10 Intestinal mucosa Th17 ◉ 
LINC.PINT 4.89E-01 3.95E-10 Intestinal mucosa Th17  
RP11.631M6.2 3.95E-01 1.55E-09 Intestinal mucosa Th17  
ANKHD1 6.47E-01 1.71E-09 Intestinal mucosa Th17  
SNHG12 2.86E-01 3.06E-09 Intestinal mucosa Th17  
CLDND1 6.63E-01 1.45E-08 Intestinal mucosa Th17  
TSC22D2 4.38E-01 2.21E-08 Intestinal mucosa Th17 ◉ 
ISG15 6.10E-01 2.42E-08 Intestinal mucosa Th17  
PTPN22 4.53E-01 3.13E-08 Intestinal mucosa Th17 ✘ 
TP53INP1 5.00E-01 1.56E-07 Intestinal mucosa Th17  
CHD2 5.33E-01 1.87E-07 Intestinal mucosa Th17 ◉ 
HES4 3.99E-01 1.99E-07 Intestinal mucosa Th17 ◉ 
RP11.138A9.1 5.05E-01 2.49E-07 Intestinal mucosa Th17  
GNL3 5.16E-01 2.71E-07 Intestinal mucosa Th17  
AC092580.4 4.92E-01 3.48E-07 Intestinal mucosa Th17  
DNAJB4 4.84E-01 4.24E-07 Intestinal mucosa Th17 ✘ 
GFPT2 3.76E-01 4.30E-07 Intestinal mucosa Th17  
TIPARP 7.20E-01 4.66E-07 Intestinal mucosa Th17 ◉ 
DHX36 4.05E-01 6.87E-07 Intestinal mucosa Th17  
CYCS 8.36E-01 7.24E-07 Intestinal mucosa Th17  
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annotation 
STRN3 4.36E-01 3.24E-06 Intestinal mucosa Th17  
LRRC1 4.00E-01 4.56E-06 Intestinal mucosa Th17  
PTBP2 3.99E-01 6.32E-06 Intestinal mucosa Th17  
UBE2B 3.62E-01 6.48E-06 Intestinal mucosa Th17  
ARHGEF7 4.56E-01 7.35E-06 Intestinal mucosa Th17  
RP11.727F15.9 5.28E-01 7.46E-06 Intestinal mucosa Th17  
RHOH 4.87E-01 7.91E-06 Intestinal mucosa Th17  
LDLR 4.20E-01 8.22E-06 Intestinal mucosa Th17  
ZBTB10 4.10E-01 9.07E-06 Intestinal mucosa Th17 ◉ 
CTB.131B5.2 3.62E-01 9.32E-06 Intestinal mucosa Th17  
H3F3B 4.60E-01 9.46E-06 Intestinal mucosa Th17  
DEFA5 2.99E-01 1.04E-05 Intestinal mucosa Th17 ✸ 
TANK 4.51E-01 1.06E-05 Intestinal mucosa Th17  
ERN1 5.39E-01 1.32E-05 Intestinal mucosa Th17  
ZBTB25 4.18E-01 1.56E-05 Intestinal mucosa Th17 ◉ 
HECA 5.08E-01 1.56E-05 Intestinal mucosa Th17  
NOP58 3.89E-01 1.58E-05 Intestinal mucosa Th17  
NASP 3.57E-01 2.40E-05 Intestinal mucosa Th17  
GPR34 5.99E-01 2.73E-05 Intestinal mucosa Th17  
DOCK11 4.54E-01 2.83E-05 Intestinal mucosa Th17  
SYTL3 7.15E-01 2.99E-05 Intestinal mucosa Th17  
RP11.297H3.3 6.31E-01 3.56E-05 Intestinal mucosa Th17  
CCL4 9.08E-01 3.66E-05 Intestinal mucosa Th17 ✸ 
TSPYL2 7.38E-01 3.93E-05 Intestinal mucosa Th17  
WDR74 3.58E-01 5.73E-05 Intestinal mucosa Th17  
CHMP1B 5.35E-01 6.03E-05 Intestinal mucosa Th17  
STRAP 4.98E-01 7.87E-05 Intestinal mucosa Th17  
OSTF1 3.75E-01 9.02E-05 Intestinal mucosa Th17  
CTD.2636A23.2 2.54E-01 1.43E-04 Intestinal mucosa Th17  
LZTFL1 3.36E-01 1.60E-04 Intestinal mucosa Th17  
KLRB1 5.69E-01 2.27E-04 Intestinal mucosa Th17  
SH2D2A 5.69E-01 2.63E-04 Intestinal mucosa Th17  
SHISA2 4.90E-01 2.78E-04 Intestinal mucosa Th17  
DDX3X 3.11E-01 2.81E-04 Intestinal mucosa Th17  
HSPA6 4.77E-01 3.12E-04 Intestinal mucosa Th17  
STIP1 4.22E-01 3.50E-04 Intestinal mucosa Th17  
PIK3R1 7.36E-01 3.53E-04 Intestinal mucosa Th17  
ETV3 4.55E-01 4.25E-04 Intestinal mucosa Th17 ◉ 
ZNF267 4.35E-01 4.54E-04 Intestinal mucosa Th17 ◉ 


















Compartment Cell type Gene 
annotation 
CFAP20 6.38E-01 8.83E-04 Intestinal mucosa Th17  
G3BP2 4.94E-01 9.43E-04 Intestinal mucosa Th17  
ZC3H12A 5.09E-01 9.88E-04 Intestinal mucosa Th17  
ITGA1 7.52E-01 1.24E-03 Intestinal mucosa Th17  
RP3.370M22.8 4.11E-01 1.26E-03 Intestinal mucosa Th17  
PPP3CA 3.55E-01 1.69E-03 Intestinal mucosa Th17  
AUTS2 3.08E-01 1.73E-03 Intestinal mucosa Th17  
SOCS1 6.59E-01 1.78E-03 Intestinal mucosa Th17 ✘ 
CEBPZ 2.89E-01 2.43E-03 Intestinal mucosa Th17 ◉ 
REL 3.88E-01 4.08E-03 Intestinal mucosa Th17 ✘ ◉ 
FAM177A1 5.57E-01 4.57E-03 Intestinal mucosa Th17  
TAGAP 5.94E-01 6.05E-03 Intestinal mucosa Th17 ✘ 
RNF19A 3.25E-01 9.96E-03 Intestinal mucosa Th17  
GABARAPL1 3.19E-01 1.02E-02 Intestinal mucosa Th17  
NABP1 2.73E-01 1.16E-02 Intestinal mucosa Th17  
GALK2 4.63E-01 1.18E-02 Intestinal mucosa Th17  
BTG3 5.26E-01 1.40E-02 Intestinal mucosa Th17  
COCH 2.63E-01 1.64E-02 Intestinal mucosa Th17  
ZFP36L1 3.82E-01 2.02E-02 Intestinal mucosa Th17 ✘ ◉ 
DCTN6 3.41E-01 2.20E-02 Intestinal mucosa Th17  
PAPOLA 5.16E-01 2.39E-02 Intestinal mucosa Th17  
IL2 3.81E-01 2.59E-02 Intestinal mucosa Th17 ✸ 
ZC3H12D 3.08E-01 2.74E-02 Intestinal mucosa Th17  
KPNA2 4.57E-01 3.42E-02 Intestinal mucosa Th17  
GPR35 2.99E-01 3.68E-02 Intestinal mucosa Th17  
ARL4D 4.03E-01 4.22E-02 Intestinal mucosa Th17  
NUP58 4.79E-01 4.40E-02 Intestinal mucosa Th17  
S100A4 6.18E-01 3.44E-67 Peripheral blood  Effector/Treg  
LTB 7.50E-01 6.76E-62 Peripheral blood  Effector/Treg ✸ 
TOB1 5.29E-01 8.63E-45 Peripheral blood  Effector/Treg  
C16orf54 3.13E-01 7.21E-43 Peripheral blood  Effector/Treg  
CD52 4.09E-01 2.02E-41 Peripheral blood  Effector/Treg  
IL32 3.94E-01 2.07E-39 Peripheral blood  Effector/Treg ✸ 
TMSB10 3.63E-01 3.36E-36 Peripheral blood  Effector/Treg  
EMP3 2.58E-01 2.64E-33 Peripheral blood  Effector/Treg  
TNFRSF25 3.83E-01 2.37E-29 Peripheral blood  Effector/Treg  
RAP2B 3.64E-01 2.35E-28 Peripheral blood  Effector/Treg  
RASSF3 2.66E-01 2.52E-28 Peripheral blood  Effector/Treg  
S100A11 4.07E-01 4.78E-25 Peripheral blood  Effector/Treg  


















Compartment Cell type Gene 
annotation 
CALM1 2.96E-01 1.48E-24 Peripheral blood  Effector/Treg  
RPL13A 3.30E-01 6.10E-24 Peripheral blood  Effector/Treg  
TTC39C 2.73E-01 9.43E-23 Peripheral blood  Effector/Treg  
RUNX2 6.60E-01 8.29E-22 Peripheral blood  Effector/Treg ◉ 
ADAM19 3.99E-01 1.67E-21 Peripheral blood  Effector/Treg  
FAM65B 3.16E-01 2.22E-21 Peripheral blood  Effector/Treg  
SH3BGRL3 3.48E-01 1.02E-19 Peripheral blood  Effector/Treg  
AES 2.73E-01 1.75E-18 Peripheral blood  Effector/Treg  
TTC39C.AS1 4.49E-01 1.21E-17 Peripheral blood  Effector/Treg  
FLNA 4.53E-01 6.53E-17 Peripheral blood  Effector/Treg  
FUT7 3.14E-01 2.06E-16 Peripheral blood  Effector/Treg  
SOCS2 6.58E-01 2.85E-16 Peripheral blood  Effector/Treg  
PIM1 5.37E-01 2.92E-16 Peripheral blood  Effector/Treg  
MORC2.AS1 3.79E-01 3.47E-16 Peripheral blood  Effector/Treg  
PSME1 2.80E-01 1.42E-15 Peripheral blood  Effector/Treg  
MORC2 4.93E-01 8.75E-15 Peripheral blood  Effector/Treg  
TESPA1 3.74E-01 1.36E-14 Peripheral blood  Effector/Treg  
RPL5 2.80E-01 6.17E-14 Peripheral blood  Effector/Treg  
PCED1B.AS1 2.70E-01 9.66E-14 Peripheral blood  Effector/Treg  
PLP2 5.98E-01 1.38E-13 Peripheral blood  Effector/Treg  
PTPN13 4.66E-01 1.47E-13 Peripheral blood  Effector/Treg  
CMTM6 4.78E-01 1.93E-13 Peripheral blood  Effector/Treg ✸ 
S1PR1 4.97E-01 2.43E-13 Peripheral blood  Effector/Treg ◁ 
RPLP0 2.57E-01 2.75E-13 Peripheral blood  Effector/Treg  
TNFRSF4 4.85E-01 8.03E-13 Peripheral blood  Effector/Treg ✘ 
ANXA2 4.32E-01 9.76E-13 Peripheral blood  Effector/Treg  
S100A10 5.28E-01 1.29E-12 Peripheral blood  Effector/Treg  
CTSH 5.95E-01 1.98E-12 Peripheral blood  Effector/Treg  
P2RY8 4.81E-01 2.34E-12 Peripheral blood  Effector/Treg  
BIN2 4.23E-01 4.11E-12 Peripheral blood  Effector/Treg  
C21orf33 2.61E-01 4.25E-12 Peripheral blood  Effector/Treg  
SLC25A6 3.23E-01 5.05E-12 Peripheral blood  Effector/Treg  
NOSIP 6.04E-01 5.06E-12 Peripheral blood  Effector/Treg  
USP10 5.74E-01 3.09E-11 Peripheral blood  Effector/Treg  
TSPO 6.49E-01 3.11E-11 Peripheral blood  Effector/Treg  
IL7R 2.83E-01 4.13E-11 Peripheral blood  Effector/Treg  
RPL4 2.84E-01 9.82E-11 Peripheral blood  Effector/Treg  
TIMP1 5.64E-01 1.13E-10 Peripheral blood  Effector/Treg  
NPDC1 3.83E-01 1.38E-10 Peripheral blood  Effector/Treg  


















Compartment Cell type Gene 
annotation 
RPL18 2.56E-01 1.28E-09 Peripheral blood  Effector/Treg  
TRAT1 4.50E-01 1.38E-09 Peripheral blood  Effector/Treg  
MAP3K1 5.20E-01 3.08E-09 Peripheral blood  Effector/Treg  
CAPN2 4.85E-01 5.43E-09 Peripheral blood  Effector/Treg  
GBP5 4.51E-01 1.05E-08 Peripheral blood  Effector/Treg  
SVIL 4.19E-01 1.16E-08 Peripheral blood  Effector/Treg  
HSD11B1 3.86E-01 1.33E-08 Peripheral blood  Effector/Treg  
AQP3 4.76E-01 1.77E-08 Peripheral blood  Effector/Treg  
CDC25B 3.66E-01 4.66E-08 Peripheral blood  Effector/Treg  
GTF3A 4.03E-01 5.53E-08 Peripheral blood  Effector/Treg ◉ 
C12orf75 6.12E-01 7.35E-08 Peripheral blood  Effector/Treg  
CISH 5.24E-01 8.45E-08 Peripheral blood  Effector/Treg  
GLUL 5.11E-01 9.62E-08 Peripheral blood  Effector/Treg  
MFNG 3.79E-01 1.26E-07 Peripheral blood  Effector/Treg  
PDIA4 2.81E-01 2.34E-07 Peripheral blood  Effector/Treg  
LDHB 2.59E-01 2.97E-07 Peripheral blood  Effector/Treg  
RP11.356J5.12 5.69E-01 3.68E-07 Peripheral blood  Effector/Treg  
IL10RA 3.29E-01 6.00E-07 Peripheral blood  Effector/Treg  
ARPC1B 2.70E-01 6.26E-07 Peripheral blood  Effector/Treg  
ITGB2 2.74E-01 7.35E-07 Peripheral blood  Effector/Treg  
PDCD5 5.30E-01 7.94E-07 Peripheral blood  Effector/Treg  
SLC40A1 3.77E-01 8.32E-07 Peripheral blood  Effector/Treg  
YWHAQ 2.85E-01 2.17E-06 Peripheral blood  Effector/Treg  
ELK3 4.46E-01 2.71E-06 Peripheral blood  Effector/Treg ◉ 
NECAP2 4.12E-01 3.59E-06 Peripheral blood  Effector/Treg  
ELOVL4 3.71E-01 4.33E-06 Peripheral blood  Effector/Treg  
MOSPD3 3.37E-01 5.23E-06 Peripheral blood  Effector/Treg  
PSMB8 3.76E-01 5.97E-06 Peripheral blood  Effector/Treg  
TRADD 4.01E-01 7.02E-06 Peripheral blood  Effector/Treg  
SSR4 2.66E-01 2.17E-05 Peripheral blood  Effector/Treg  
TXN 3.24E-01 2.26E-05 Peripheral blood  Effector/Treg  
MYC 4.04E-01 3.83E-05 Peripheral blood  Effector/Treg ◉ 
TEX264 5.62E-01 1.17E-04 Peripheral blood  Effector/Treg  
JAKMIP1 2.71E-01 1.18E-04 Peripheral blood  Effector/Treg  
RNASET2 3.30E-01 1.27E-04 Peripheral blood  Effector/Treg ✘ 
LTK 2.74E-01 1.67E-04 Peripheral blood  Effector/Treg  
PLEKHG3 2.65E-01 1.74E-04 Peripheral blood  Effector/Treg  
CNN2 2.68E-01 1.76E-04 Peripheral blood  Effector/Treg  
MT.TT 2.81E-01 2.00E-04 Peripheral blood  Effector/Treg  
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BIN1 3.85E-01 2.25E-04 Peripheral blood  Effector/Treg  
C10orf54 4.48E-01 2.46E-04 Peripheral blood  Effector/Treg  
REXO2 3.75E-01 3.66E-04 Peripheral blood  Effector/Treg  
TC2N 3.17E-01 4.28E-04 Peripheral blood  Effector/Treg  
DPP4 2.50E-01 5.66E-04 Peripheral blood  Effector/Treg  
ENO1 3.00E-01 6.73E-04 Peripheral blood  Effector/Treg  
NSG1 3.90E-01 7.02E-04 Peripheral blood  Effector/Treg  
HINT1 2.60E-01 7.02E-04 Peripheral blood  Effector/Treg  
SIT1 3.32E-01 1.78E-03 Peripheral blood  Effector/Treg  
TRAF3IP3 2.91E-01 2.04E-03 Peripheral blood  Effector/Treg  
SEC61B 2.59E-01 2.44E-03 Peripheral blood  Effector/Treg  
CCR2 2.93E-01 2.56E-03 Peripheral blood  Effector/Treg ✘ 
ICAM2 4.66E-01 3.01E-03 Peripheral blood  Effector/Treg  
ATP5F1 2.98E-01 5.84E-03 Peripheral blood  Effector/Treg  
RIPK2 4.75E-01 6.17E-03 Peripheral blood  Effector/Treg ✘ 
CBLL1 3.34E-01 6.32E-03 Peripheral blood  Effector/Treg ◉ 
LRRFIP1 2.80E-01 6.58E-03 Peripheral blood  Effector/Treg  
S1PR4 3.74E-01 7.70E-03 Peripheral blood  Effector/Treg ◁ 
EIF4EBP2 2.69E-01 8.50E-03 Peripheral blood  Effector/Treg  
CPT1A 2.54E-01 9.14E-03 Peripheral blood  Effector/Treg  
SYTL1 2.86E-01 1.06E-02 Peripheral blood  Effector/Treg  
SLIRP 3.02E-01 1.25E-02 Peripheral blood  Effector/Treg  
TNFAIP8 2.91E-01 1.29E-02 Peripheral blood  Effector/Treg  
RSU1 3.85E-01 1.64E-02 Peripheral blood  Effector/Treg  
ARL14EP 2.70E-01 1.79E-02 Peripheral blood  Effector/Treg  
CYTH1 2.57E-01 1.90E-02 Peripheral blood  Effector/Treg  
MAT2B 3.02E-01 2.12E-02 Peripheral blood  Effector/Treg  
LPAR6 3.77E-01 2.42E-02 Peripheral blood  Effector/Treg  
EAF1 2.78E-01 2.58E-02 Peripheral blood  Effector/Treg  
CARD16 3.12E-01 2.76E-02 Peripheral blood  Effector/Treg  
SMDT1 2.67E-01 3.69E-02 Peripheral blood  Effector/Treg  
MYO1F 3.07E-01 4.61E-02 Peripheral blood  Effector/Treg  
CDC42SE1 9.05E-01 8.32E-44 Peripheral blood Treg/Quiescent  
C1orf56 9.03E-01 3.44E-42 Peripheral blood Treg/Quiescent  
HNRNPH1 7.20E-01 1.88E-37 Peripheral blood Treg/Quiescent  
MTA2 6.33E-01 1.15E-12 Peripheral blood Treg/Quiescent ◉ 
C16orf54 7.99E-01 8.09E-12 Peripheral blood Treg/Quiescent  
HNRNPL 5.86E-01 2.67E-11 Peripheral blood Treg/Quiescent  
SRSF6 5.83E-01 2.37E-07 Peripheral blood Treg/Quiescent  
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EIF5A 4.91E-01 1.62E-06 Peripheral blood Treg/Quiescent  
CTNNB1 5.27E-01 7.67E-06 Peripheral blood Treg/Quiescent  
CTBP1 7.36E-01 3.51E-05 Peripheral blood Treg/Quiescent  
SAR1A 3.91E-01 4.35E-05 Peripheral blood Treg/Quiescent  
MPRIP 8.35E-01 4.67E-04 Peripheral blood Treg/Quiescent  
GIGYF1 6.07E-01 6.64E-04 Peripheral blood Treg/Quiescent  
PCBP2 4.81E-01 1.06E-03 Peripheral blood Treg/Quiescent  
POLR2J3 4.20E-01 1.43E-03 Peripheral blood Treg/Quiescent  
B4GALT1 4.09E-01 6.54E-03 Peripheral blood Treg/Quiescent  
RAB12 7.70E-01 7.50E-03 Peripheral blood Treg/Quiescent  
WTAP 4.85E-01 2.68E-02 Peripheral blood Treg/Quiescent  
C6orf62 4.52E-01 3.14E-02 Peripheral blood Treg/Quiescent  
NOG 9.18E-01 3.82E-02 Peripheral blood Treg/Quiescent  
FLVCR2 6.93E-01 4.00E-96 Intestinal mucosa Treg/Quiescent  
SYT8 7.73E-01 2.91E-54 Intestinal mucosa Treg/Quiescent  
MTND4P12 6.81E-01 1.20E-43 Intestinal mucosa Treg/Quiescent  
CXCR5 1.02E+00 2.40E-35 Intestinal mucosa Treg/Quiescent ✘ 
ICA1 8.77E-01 4.83E-24 Intestinal mucosa Treg/Quiescent  
ST8SIA1 8.56E-01 1.68E-22 Intestinal mucosa Treg/Quiescent  
RPL13P12 2.96E-01 2.98E-20 Intestinal mucosa Treg/Quiescent  
ACTB 3.58E-01 2.90E-19 Intestinal mucosa Treg/Quiescent  
TIGIT 7.33E-01 2.18E-18 Intestinal mucosa Treg/Quiescent  
PDCD1 7.20E-01 5.88E-17 Intestinal mucosa Treg/Quiescent  
CTLA4 6.18E-01 1.73E-16 Intestinal mucosa Treg/Quiescent  
TOX2 4.45E-01 3.35E-14 Intestinal mucosa Treg/Quiescent ◉ 
TRPS1 1.11E+00 6.72E-13 Intestinal mucosa Treg/Quiescent ◉ 
KIAA1551 6.39E-01 8.18E-13 Intestinal mucosa Treg/Quiescent  
IL6ST 7.54E-01 1.62E-12 Intestinal mucosa Treg/Quiescent ✸ 
CTD.2031P19.5 6.75E-01 1.80E-11 Intestinal mucosa Treg/Quiescent  
DPP7 4.42E-01 1.13E-10 Intestinal mucosa Treg/Quiescent  
MAF 5.92E-01 7.40E-10 Intestinal mucosa Treg/Quiescent ◉ 
RP11.157G21.2 4.63E-01 7.70E-10 Intestinal mucosa Treg/Quiescent  
CHRM3.AS2 5.49E-01 2.58E-09 Intestinal mucosa Treg/Quiescent  
CD38 4.19E-01 2.66E-09 Intestinal mucosa Treg/Quiescent  
RBM6 4.69E-01 3.13E-09 Intestinal mucosa Treg/Quiescent ◉ 
RNU4.2 3.23E-01 7.10E-09 Intestinal mucosa Treg/Quiescent  
TBC1D4 6.45E-01 3.48E-08 Intestinal mucosa Treg/Quiescent  
HNRNPD 6.03E-01 3.89E-08 Intestinal mucosa Treg/Quiescent  
SDR39U1 4.53E-01 4.67E-08 Intestinal mucosa Treg/Quiescent  
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NFATC1 4.20E-01 1.32E-07 Intestinal mucosa Treg/Quiescent ✘ ◉ 
HNRNPH3 4.94E-01 2.12E-07 Intestinal mucosa Treg/Quiescent  
FOXP3 3.57E-01 4.14E-07 Intestinal mucosa Treg/Quiescent ◉ 
TUBA4A 3.10E-01 6.72E-07 Intestinal mucosa Treg/Quiescent  
PLK3 3.52E-01 1.85E-06 Intestinal mucosa Treg/Quiescent  
SIRPG 4.06E-01 2.96E-06 Intestinal mucosa Treg/Quiescent  
TOX 4.11E-01 3.82E-06 Intestinal mucosa Treg/Quiescent ◉ 
EPHB6 4.86E-01 3.83E-06 Intestinal mucosa Treg/Quiescent  
NABP1 5.00E-01 5.93E-06 Intestinal mucosa Treg/Quiescent  
PASK 5.30E-01 6.62E-06 Intestinal mucosa Treg/Quiescent  
DGKA 5.52E-01 2.47E-05 Intestinal mucosa Treg/Quiescent  
FAN1 2.62E-01 3.71E-05 Intestinal mucosa Treg/Quiescent  
SP110 6.01E-01 4.94E-05 Intestinal mucosa Treg/Quiescent ◉ 
CMTM7 5.50E-01 7.78E-05 Intestinal mucosa Treg/Quiescent ✸ 
DNPH1 4.84E-01 8.22E-05 Intestinal mucosa Treg/Quiescent  
PTPN7 2.52E-01 1.03E-04 Intestinal mucosa Treg/Quiescent  
ACAD10 2.98E-01 1.23E-04 Intestinal mucosa Treg/Quiescent  
FCMR 4.05E-01 1.81E-04 Intestinal mucosa Treg/Quiescent  
CTSB 4.70E-01 7.16E-04 Intestinal mucosa Treg/Quiescent  
CDK5R1 3.16E-01 7.16E-04 Intestinal mucosa Treg/Quiescent  
PVT1 3.51E-01 7.28E-04 Intestinal mucosa Treg/Quiescent  
AHI1 3.73E-01 7.32E-04 Intestinal mucosa Treg/Quiescent  
TLK1 4.47E-01 7.88E-04 Intestinal mucosa Treg/Quiescent  
ZNF251 3.00E-01 9.69E-04 Intestinal mucosa Treg/Quiescent ◉ 
RNA28S5 4.14E-01 1.02E-03 Intestinal mucosa Treg/Quiescent     
TMEM2 3.63E-01 1.03E-03 Intestinal mucosa Treg/Quiescent     
PTPRCAP 4.02E-01 1.15E-03 Intestinal mucosa Treg/Quiescent     
SESN3 5.10E-01 1.27E-03 Intestinal mucosa Treg/Quiescent     
AFTPH 2.81E-01 1.76E-03 Intestinal mucosa Treg/Quiescent     
UBA6.AS1 2.87E-01 1.87E-03 Intestinal mucosa Treg/Quiescent     
FYB 4.33E-01 3.79E-03 Intestinal mucosa Treg/Quiescent     
TSEN34 2.54E-01 4.12E-03 Intestinal mucosa Treg/Quiescent   
SELENOM 3.23E-01 4.65E-03 Intestinal mucosa Treg/Quiescent     
PVALB 2.96E-01 5.27E-03 Intestinal mucosa Treg/Quiescent   
RPL10 2.50E-01 6.18E-03 Intestinal mucosa Treg/Quiescent     
MBOAT1 2.53E-01 8.03E-03 Intestinal mucosa Treg/Quiescent     
RPS5 3.32E-01 1.33E-02 Intestinal mucosa Treg/Quiescent     
ZC2HC1A 3.14E-01 2.14E-02 Intestinal mucosa Treg/Quiescent     
SYPL1 4.76E-01 2.24E-02 Intestinal mucosa Treg/Quiescent     
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MTATP6P1 3.58E-01 2.69E-02 Intestinal mucosa Treg/Quiescent     
LINC00847 3.50E-01 2.91E-02 Intestinal mucosa Treg/Quiescent   
VWA5A 2.77E-01 3.01E-02 Intestinal mucosa Treg/Quiescent     
CD59 4.71E-01 3.23E-02 Intestinal mucosa Treg/Quiescent     














Supplementary Table 2: Specification for materials and resources 
  Reagent or resource Source Identifier/version 
Antibodies Anti-Human CD3 APC e780  eBioscience 47-0036-42 
  Anti-Human CD8α APC Biolegend 300912 
  Anti-Human CD8β APC BD Biosciences 641058 
  Anti-Human CD19 APC r700 BD Biosciences 564977 
  Anti-Human CD45RO BV421 BD Biosciences 562641 
  Anti-Human CD62L PE Biolegend 304806 
  Anti-Human CD326 PercpCy5.5 Biolegend 324214 
  Anti-Human αβTCR FITC eBioscience 11-9986-42 
  Propidium iodide  Sigma 4170 
 Anti-Human REG1A monoclonal antibody Thermo Fisher Scientific MA5-15524 
 Anti-Human CD3 polyclonal antibody Abcam ab5690 
Commercial kits Nextera XT DNA sample preparation kit  Illumina FC-131-1096 
  Nextera XT 24-index kit Illumina FC-131-1001 
  HT DNA HiSense extended range labchip PerkinElmer 760517 
  High output flowcell cartridge v2, 75bp kit. Illumina 15065973 
Reagents Lymphoprep solution STEMCELL  7801 
  RPMI 1640 (+nil)  Thermo Fisher Scientific 61870-010 
  HBSS -CMF  Thermo Fisher Scientific 14175-053 
  EDTA  (0.5M) Sigma-Aldrich 3690 
  DTT (0.5M) Thermo Fisher Scientific   
  Collagenase IV  Sigma C1889 
  DNAse II type V  Sigma  D8764 
  SUPERase•In™ RNase Inhibitor Thermo Fisher Scientific AM2696 
  PW1 Illumina in Sequencing Kit 
  KAPA HiFi HotStart ReadyMix Sopachem- KAPA Biosystems KK2601 
  EB solution 10 mM Tris-Cl, pH 8.5 Qiagen 19086 













  Agencourt Ampure XP beads Beckman Coulter A 63881 
  Betaine BioUltra ≥99.0% Sigma-Aldrich 61962 
  Triton X-100 Sigma-Aldrich T9284 
  dNTP mix Westburg-Fermentas R0192 
  Recombinant RNase inhibitor Westburg-Clontech 2313A 
  SmartScribe reverse transcriptase Westburg-Clontech CL639537 
  DNA-OFF Westburg-Takara Bio 9036 
  First-strand buffer LifeTechnologies 18064-014 
  DTT LifeTechnologies 18064-014 
  RNaseZap LifeTechnologies AM9780 
Oligonucleotides BC-TSO:                  AAGCAGTGGTATCAACGCAGAGTGAATrGrG+G Biolegio Custom design 
  BC-PCR:                  AAGCAGTGGTATCAACGCAGAGT Biolegio Custom design 
  BC-Read1Primer: GCCTGTCCGCGGAAGCAGTGGTATCAACGCAGAGTAC Biolegio Custom design 
  P5-TSO-hybrid:     AATGATACGGCGACCACCGAGATCTACAC - Biolegio Custom design 
                                  GCCTGTCCGCGGAAGCAGTGGTATCAACGCAGAGT*A*C    
Software Summit  Beckman Coulter v. 6.3.1 
  DropSeq  Macosko, 2015 v. 1.12 
  STAR Dobin, 2013 v 2.5 
  Picard http://broadinstitute.github.io/picard/ v. 2.10 
  R https://www.r-project.org/ 3.4.2 
  Seurat Macosko, 2015 2.1.0 
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  SCONE Cole and Risso, 2017 v 1.1.3 
  Kaluza Beckman Coulter v 1.5a 
  ReactomePA Yu and He, 2016  1.22.0 














Supplementary Figure Legends: 
 
 
Supplementary Figure 1: t-SNE plots representing T cells pooled from three individual 
patients with Crohn’s disease. A) t-SNE plot representing transcriptomes from T cells in 
peripheral blood (circles) and intestinal mucosa (triangles). B) t-SNE plot representing 
transcriptomes from intestinal mucosal T cells as depicted in panel A. IEL are presented as 
circles, LPL as triangles. C) t-SNE plot indicating the presence of surface markers on intestinal 
mucosal T cells, measured by flow-cytometry, in a binary fashion. D-G) t-SNE plots featuring 
expression of cellular marker genes in intestinal mucosal T cells. Plots represent gene 
expression values of a particular gene, measured by single-cell RNA sequencing, ranging 
from Q0-Q75 of normalized expression values per gene. IEL: intraepithelial T lymphocyte. 
LPL: lamina propria T lymphocyte. CTL: Cytotoxic T lymphocytes.  Quiescent: Quiescent T 
lymphocytes. REG1A/1B: cells highly expressing REG1A/1B, without expressing Paneth cell 
markers. Th17: T-helper 17 cells. Effector/Treg: T-regulatory lymphocytes on an effector 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1B: T-cell subtypes in IEL and LPL mucosa
1A: T-cell subtypes in blood and mucosa
1E: Marker-gene expression in mucosal Treg/Quiescent 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1G: REG1A/REG1B-cell gene expression, 
        no Paneth cell marker-gene expression 
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